<article article-type="article" specific-use="production" xml:lang="en" xmlns:hw="org.highwire.hpp" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:ref="http://schema.highwire.org/Reference" xmlns:hwp="http://schema.highwire.org/Journal" xmlns:l="http://schema.highwire.org/Linking" xmlns:r="http://schema.highwire.org/Revision" xmlns:x="http://www.w3.org/1999/xhtml" xmlns:app="http://www.w3.org/2007/app" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:nlm="http://schema.highwire.org/NLM/Journal" xmlns:a="http://www.w3.org/2005/Atom" xmlns:c="http://schema.highwire.org/Compound" xmlns:hpp="http://schema.highwire.org/Publishing"><front><journal-meta><journal-id journal-id-type="hwp">biorxiv</journal-id><journal-id journal-id-type="publisher-id">BIORXIV</journal-id><journal-title>bioRxiv</journal-title><abbrev-journal-title abbrev-type="publisher">bioRxiv</abbrev-journal-title><publisher><publisher-name>Cold Spring Harbor Laboratory</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.1101/068684</article-id><article-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;068684v3</article-id><article-id pub-id-type="other" hwp:sub-type="pisa-master">biorxiv;068684</article-id><article-id pub-id-type="other" hwp:sub-type="slug">068684</article-id><article-id pub-id-type="other" hwp:sub-type="atom-slug">068684</article-id><article-id pub-id-type="other" hwp:sub-type="tag">068684</article-id><article-version>1.3</article-version><article-categories><subj-group subj-group-type="author-type"><subject>Regular Article</subject></subj-group><subj-group subj-group-type="heading"><subject>New Results</subject></subj-group><subj-group subj-group-type="hwp-journal-coll" hwp:journal-coll-id="Genetics" hwp:journal="biorxiv"><subject>Genetics</subject></subj-group></article-categories><title-group><article-title hwp:id="article-title-1">Cross-disorder analysis of schizophrenia and 19 immune diseases reveals genetic correlation</article-title></title-group><author-notes hwp:id="author-notes-1"><corresp id="cor1" hwp:id="corresp-1" hwp:rev-id="xref-corresp-1-1 xref-corresp-1-2"><label>*</label>Corresponding authors Email: <email hwp:id="email-1">soumya@broadinstitute.org</email> (SR) Email: <email hwp:id="email-2">jo.knight@lancaster.ac.uk</email> (JK)</corresp><fn id="n1" fn-type="equal" hwp:id="fn-1" hwp:rev-id="xref-fn-1-1 xref-fn-1-2 xref-fn-1-3"><label>¶</label><p hwp:id="p-1">These authors contributed equally to this work</p></fn><fn id="n2" hwp:id="fn-2"><label>^</label><p hwp:id="p-2">Membership of the Schizophrenia Working Group of the Psychiatric Genomics Consortium is provided in the <bold>Supporting Information</bold>.</p></fn></author-notes><contrib-group hwp:id="contrib-group-1"><contrib contrib-type="author" hwp:id="contrib-1"><name name-style="western" hwp:sortable="Pouget Jennie G"><surname>Pouget</surname><given-names>Jennie G</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-1" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-1" hwp:rel-id="aff-2">2</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-1" hwp:rel-id="aff-3">3</xref></contrib><contrib contrib-type="author" hwp:id="contrib-2"><collab hwp:id="collab-1">Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-1" hwp:rel-id="fn-1">^</xref></contrib><contrib contrib-type="author" hwp:id="contrib-3"><name name-style="western" hwp:sortable="Han Buhm"><surname>Han</surname><given-names>Buhm</given-names></name><xref ref-type="aff" rid="a4" hwp:id="xref-aff-4-1" hwp:rel-id="aff-4">4</xref></contrib><contrib contrib-type="author" hwp:id="contrib-4"><name name-style="western" hwp:sortable="Wu Yang"><surname>Wu</surname><given-names>Yang</given-names></name><xref ref-type="aff" rid="a5" hwp:id="xref-aff-5-1" hwp:rel-id="aff-5">5</xref></contrib><contrib contrib-type="author" hwp:id="contrib-5"><name name-style="western" hwp:sortable="Mignot Emmanuel"><surname>Mignot</surname><given-names>Emmanuel</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-1" hwp:rel-id="aff-6">6</xref></contrib><contrib contrib-type="author" hwp:id="contrib-6"><name name-style="western" hwp:sortable="Ollila Hanna M"><surname>Ollila</surname><given-names>Hanna M</given-names></name><xref ref-type="aff" rid="a6" hwp:id="xref-aff-6-2" hwp:rel-id="aff-6">6</xref><xref ref-type="aff" rid="a7" hwp:id="xref-aff-7-1" hwp:rel-id="aff-7">7</xref><xref ref-type="aff" rid="a8" hwp:id="xref-aff-8-1" hwp:rel-id="aff-8">8</xref></contrib><contrib contrib-type="author" hwp:id="contrib-7"><name name-style="western" hwp:sortable="Barker Jonathan"><surname>Barker</surname><given-names>Jonathan</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-1" hwp:rel-id="aff-9">9</xref><xref ref-type="aff" rid="a10" hwp:id="xref-aff-10-1" hwp:rel-id="aff-10">10</xref></contrib><contrib contrib-type="author" hwp:id="contrib-8"><name name-style="western" hwp:sortable="Spain Sarah"><surname>Spain</surname><given-names>Sarah</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-2" hwp:rel-id="aff-9">9</xref><xref ref-type="aff" rid="a11" hwp:id="xref-aff-11-1" hwp:rel-id="aff-11">11</xref></contrib><contrib contrib-type="author" hwp:id="contrib-9"><name name-style="western" hwp:sortable="Dand Nick"><surname>Dand</surname><given-names>Nick</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-3" hwp:rel-id="aff-9">9</xref></contrib><contrib contrib-type="author" hwp:id="contrib-10"><name name-style="western" hwp:sortable="Trembath Richard"><surname>Trembath</surname><given-names>Richard</given-names></name><xref ref-type="aff" rid="a9" hwp:id="xref-aff-9-4" hwp:rel-id="aff-9">9</xref><xref ref-type="aff" rid="a12" hwp:id="xref-aff-12-1" hwp:rel-id="aff-12">12</xref></contrib><contrib contrib-type="author" hwp:id="contrib-11"><name name-style="western" hwp:sortable="Martin Javier"><surname>Martin</surname><given-names>Javier</given-names></name><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-1" hwp:rel-id="aff-13">13</xref></contrib><contrib contrib-type="author" hwp:id="contrib-12"><name name-style="western" hwp:sortable="Mayes Maureen D"><surname>Mayes</surname><given-names>Maureen D</given-names></name><xref ref-type="aff" rid="a14" hwp:id="xref-aff-14-1" hwp:rel-id="aff-14">14</xref></contrib><contrib contrib-type="author" hwp:id="contrib-13"><name name-style="western" hwp:sortable="Bossini-Castillo Lara"><surname>Bossini-Castillo</surname><given-names>Lara</given-names></name><xref ref-type="aff" rid="a11" hwp:id="xref-aff-11-2" hwp:rel-id="aff-11">11</xref></contrib><contrib contrib-type="author" hwp:id="contrib-14"><name name-style="western" hwp:sortable="López-Isac Elena"><surname>López-Isac</surname><given-names>Elena</given-names></name><xref ref-type="aff" rid="a13" hwp:id="xref-aff-13-2" hwp:rel-id="aff-13">13</xref></contrib><contrib contrib-type="author" hwp:id="contrib-15"><name name-style="western" hwp:sortable="Jin Ying"><surname>Jin</surname><given-names>Ying</given-names></name><xref ref-type="aff" rid="a15" hwp:id="xref-aff-15-1" hwp:rel-id="aff-15">15</xref><xref ref-type="aff" rid="a16" hwp:id="xref-aff-16-1" hwp:rel-id="aff-16">16</xref></contrib><contrib contrib-type="author" hwp:id="contrib-16"><name name-style="western" hwp:sortable="Santorico Stephanie A"><surname>Santorico</surname><given-names>Stephanie A</given-names></name><xref ref-type="aff" rid="a15" hwp:id="xref-aff-15-2" hwp:rel-id="aff-15">15</xref><xref ref-type="aff" rid="a17" hwp:id="xref-aff-17-1" hwp:rel-id="aff-17">17</xref><xref ref-type="aff" rid="a18" hwp:id="xref-aff-18-1" hwp:rel-id="aff-18">18</xref></contrib><contrib contrib-type="author" hwp:id="contrib-17"><name name-style="western" hwp:sortable="Spritz Richard A"><surname>Spritz</surname><given-names>Richard A</given-names></name><xref ref-type="aff" rid="a15" hwp:id="xref-aff-15-3" hwp:rel-id="aff-15">15</xref><xref ref-type="aff" rid="a16" hwp:id="xref-aff-16-2" hwp:rel-id="aff-16">16</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-18"><name name-style="western" hwp:sortable="Raychaudhuri Soumya"><surname>Raychaudhuri</surname><given-names>Soumya</given-names></name><xref ref-type="aff" rid="a19" hwp:id="xref-aff-19-1" hwp:rel-id="aff-19">19</xref><xref ref-type="aff" rid="a20" hwp:id="xref-aff-20-1" hwp:rel-id="aff-20">20</xref><xref ref-type="aff" rid="a21" hwp:id="xref-aff-21-1" hwp:rel-id="aff-21">21</xref><xref ref-type="aff" rid="a22" hwp:id="xref-aff-22-1" hwp:rel-id="aff-22">22</xref><xref ref-type="aff" rid="a23" hwp:id="xref-aff-23-1" hwp:rel-id="aff-23">23</xref><xref ref-type="aff" rid="a24" hwp:id="xref-aff-24-1" hwp:rel-id="aff-24">24</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-2" hwp:rel-id="fn-1">¶</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-1" hwp:rel-id="corresp-1">*</xref></contrib><contrib contrib-type="author" corresp="yes" hwp:id="contrib-19"><name name-style="western" hwp:sortable="Knight Jo"><surname>Knight</surname><given-names>Jo</given-names></name><xref ref-type="aff" rid="a1" hwp:id="xref-aff-1-2" hwp:rel-id="aff-1">1</xref><xref ref-type="aff" rid="a2" hwp:id="xref-aff-2-2" hwp:rel-id="aff-2">2</xref><xref ref-type="aff" rid="a3" hwp:id="xref-aff-3-2" hwp:rel-id="aff-3">3</xref><xref ref-type="aff" rid="a25" hwp:id="xref-aff-25-1" hwp:rel-id="aff-25">25</xref><xref ref-type="fn" rid="n1" hwp:id="xref-fn-1-3" hwp:rel-id="fn-1">¶</xref><xref ref-type="corresp" rid="cor1" hwp:id="xref-corresp-1-2" hwp:rel-id="corresp-1">*</xref></contrib><aff id="a1" hwp:id="aff-1" hwp:rev-id="xref-aff-1-1 xref-aff-1-2"><label>1</label><institution hwp:id="institution-1">Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health</institution>, Toronto, ON, <country>Canada</country></aff><aff id="a2" hwp:id="aff-2" hwp:rev-id="xref-aff-2-1 xref-aff-2-2"><label>2</label><institution hwp:id="institution-2">Institute of Medical Sciences, University of Toronto</institution>, Toronto, ON, <country>Canada</country></aff><aff id="a3" hwp:id="aff-3" hwp:rev-id="xref-aff-3-1 xref-aff-3-2"><label>3</label><institution hwp:id="institution-3">Department of Psychiatry, University of Toronto</institution>, Toronto, ON, <country>Canada</country></aff><aff id="a4" hwp:id="aff-4" hwp:rev-id="xref-aff-4-1"><label>4</label><institution hwp:id="institution-4">Department of Biomedical Sciences, Seoul National University College of Medicine</institution>, Seoul, <country>Republic of Korea</country></aff><aff id="a5" hwp:id="aff-5" hwp:rev-id="xref-aff-5-1"><label>5</label><institution hwp:id="institution-5">Institute for Molecular Bioscience, The University of Queensland</institution>, Brisbane, QLD 4072, <country>Australia</country></aff><aff id="a6" hwp:id="aff-6" hwp:rev-id="xref-aff-6-1 xref-aff-6-2"><label>6</label><institution hwp:id="institution-6">Center for Sleep Sciences and Medicine, Department of Psychiatry and Behavioral Sciences, Stanford University</institution>, School of Medicine, Palo Alto, CA, <country>USA</country></aff><aff id="a7" hwp:id="aff-7" hwp:rev-id="xref-aff-7-1"><label>7</label><institution hwp:id="institution-7">Finnish Institute for Molecular Medicine</institution>, Helsinki, <country>Finland</country></aff><aff id="a8" hwp:id="aff-8" hwp:rev-id="xref-aff-8-1"><label>8</label><institution hwp:id="institution-8">Center for Genomic Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA and Broad Institute</institution>, Cambridge, Massachusetts, <country>USA</country></aff><aff id="a9" hwp:id="aff-9" hwp:rev-id="xref-aff-9-1 xref-aff-9-2 xref-aff-9-3 xref-aff-9-4"><label>9</label><institution hwp:id="institution-9">School of Basic and Medical Biosciences, Faculty of Life Sciences and Medicine, King’s College London</institution>, <country>UK</country></aff><aff id="a10" hwp:id="aff-10" hwp:rev-id="xref-aff-10-1"><label>10</label><institution hwp:id="institution-10">St. John’s Institute of Dermatology, Faculty of Life Sciences and Medicine, King’s College London</institution>, London, <country>UK</country></aff><aff id="a11" hwp:id="aff-11" hwp:rev-id="xref-aff-11-1 xref-aff-11-2"><label>11</label><institution hwp:id="institution-11">Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus</institution>, Hinxton, Cambridge, <country>UK</country></aff><aff id="a12" hwp:id="aff-12" hwp:rev-id="xref-aff-12-1"><label>12</label><institution hwp:id="institution-12">Queen Mary University of London, Barts and the London School of Medicine and Dentistry</institution>, London, <country>UK</country></aff><aff id="a13" hwp:id="aff-13" hwp:rev-id="xref-aff-13-1 xref-aff-13-2"><label>13</label><institution hwp:id="institution-13">Institute of Parasitology and Biomedicine López-Neyra</institution>, IPBLN-CSIC, Granada, <country>Spain</country></aff><aff id="a14" hwp:id="aff-14" hwp:rev-id="xref-aff-14-1"><label>14</label><institution hwp:id="institution-14">The University of Texas Health Science Center–Houston</institution>, Houston, TX, <country>USA</country></aff><aff id="a15" hwp:id="aff-15" hwp:rev-id="xref-aff-15-1 xref-aff-15-2 xref-aff-15-3"><label>15</label><institution hwp:id="institution-15">Human Medical Genetics and Genomics Program, University of Colorado School of Medicine</institution>, Aurora, CO, <country>USA</country></aff><aff id="a16" hwp:id="aff-16" hwp:rev-id="xref-aff-16-1 xref-aff-16-2"><label>16</label><institution hwp:id="institution-16">Department of Pediatrics, University of Colorado School of Medicine</institution>, Aurora, CO, <country>USA</country></aff><aff id="a17" hwp:id="aff-17" hwp:rev-id="xref-aff-17-1"><label>17</label><institution hwp:id="institution-17">Department of Mathematical and Statistical Sciences, University of Colorado Denver</institution>, Denver, CO, <country>USA</country></aff><aff id="a18" hwp:id="aff-18" hwp:rev-id="xref-aff-18-1"><label>18</label><institution hwp:id="institution-18">Department of Biostatistics and Informatics, Colorado School of Public Health, University of Colorado</institution>, Aurora, CO, <country>USA</country></aff><aff id="a19" hwp:id="aff-19" hwp:rev-id="xref-aff-19-1"><label>19</label><institution hwp:id="institution-19">Department of Medicine, Brigham and Women's Hospital and Harvard Medical School</institution>, Boston, MA, <country>USA</country></aff><aff id="a20" hwp:id="aff-20" hwp:rev-id="xref-aff-20-1"><label>20</label><institution hwp:id="institution-20">Partners HealthCare Center for Personalized Genetic Medicine</institution>, Boston, MA, <country>USA</country></aff><aff id="a21" hwp:id="aff-21" hwp:rev-id="xref-aff-21-1"><label>21</label><institution hwp:id="institution-21">Program in Medical and Population Genetics, Broad Institute of MIT and Harvard</institution>, Cambridge, MA, <country>USA</country></aff><aff id="a22" hwp:id="aff-22" hwp:rev-id="xref-aff-22-1"><label>22</label><institution hwp:id="institution-22">Division of Genetics, Brigham and Women’s Hospital, Harvard Medical School</institution>, Boston, MA, <country>USA</country></aff><aff id="a23" hwp:id="aff-23" hwp:rev-id="xref-aff-23-1"><label>23</label><institution hwp:id="institution-23">Division of Rheumatology, Brigham and Women’s Hospital, Harvard Medical School</institution>, Boston, MA, <country>USA</country></aff><aff id="a24" hwp:id="aff-24" hwp:rev-id="xref-aff-24-1"><label>24</label><institution hwp:id="institution-24">Faculty of Medical and Human Sciences, University of Manchester</institution>, Manchester, <country>UK</country></aff><aff id="a25" hwp:id="aff-25" hwp:rev-id="xref-aff-25-1"><label>25</label><institution hwp:id="institution-25">Lancaster Medical School and Data Science Institute, Lancaster University</institution>, Lancaster, <country>UK</country></aff></contrib-group><pub-date pub-type="epub-original" date-type="pub" publication-format="electronic" hwp:start="2019"><year>2019</year></pub-date><pub-date pub-type="hwp-created" hwp:start="2016-08-09T14:09:16-07:00">
    <day>9</day><month>8</month><year>2016</year>
  </pub-date><pub-date pub-type="hwp-received" hwp:start="2019-01-30T22:15:12-08:00">
    <day>30</day><month>1</month><year>2019</year>
  </pub-date><pub-date pub-type="epub" hwp:start="2016-08-09T14:25:17-07:00">
    <day>9</day><month>8</month><year>2016</year>
  </pub-date><pub-date pub-type="epub-version" hwp:start="2019-01-30T22:20:53-08:00">
    <day>30</day><month>1</month><year>2019</year>
  </pub-date><elocation-id>068684</elocation-id><history hwp:id="history-1">
<date date-type="received" hwp:start="2016-08-09"><day>09</day><month>8</month><year>2016</year></date>
<date date-type="rev-recd" hwp:start="2019-01-30"><day>30</day><month>1</month><year>2019</year></date>
<date date-type="accepted" hwp:start="2019-01-30"><day>30</day><month>1</month><year>2019</year></date>
</history><permissions><copyright-statement hwp:id="copyright-statement-1">© 2019, Posted by Cold Spring Harbor Laboratory</copyright-statement><copyright-year>2019</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="license-1"><p hwp:id="p-3">This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/" hwp:id="ext-link-1">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link></p></license></permissions><self-uri xlink:href="068684.pdf" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/abstract" xlink:role="abstract" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:href="file:/content/biorxiv/vol0/issue2019/pdf/068684v3.pdf" hwp:variant="yes" content-type="pdf" xlink:role="full-text"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/full-text" xlink:role="full-text" content-type="xhtml+xml" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/source" xlink:role="source" content-type="xml" xlink:show="none" hwp:variant="yes"/><self-uri l:ref="forthcoming:yes" c:role="http://schema.highwire.org/variant/original" xlink:role="original" content-type="xml" xlink:show="none" hwp:variant="yes" xlink:href="068684.xml"/><self-uri content-type="abstract" xlink:href="file:/content/biorxiv/vol0/issue2019/abstracts/068684v3/068684v3.htslp"/><self-uri content-type="fulltext" xlink:href="file:/content/biorxiv/vol0/issue2019/fulltext/068684v3/068684v3.htslp"/><abstract hwp:id="abstract-1"><title hwp:id="title-1">Abstract</title><p hwp:id="p-4">Epidemiological studies indicate that many immune diseases occur at different rates among people with schizophrenia compared to the general population. Here, we evaluated whether this phenotypic correlation between immune diseases and schizophrenia might be explained by shared genetic risk factors (<bold>genetic correlation</bold>). We used data from a large genome-wide association study (GWAS) of schizophrenia (N=35,476 cases and 46,839 controls) to compare the genetic architecture of schizophrenia to 19 immune diseases. First, we evaluated the association with schizophrenia of 581 variants previously reported to be associated with immune diseases at genome-wide significance. We identified three variants with pleiotropic effects, located in regions associated with both schizophrenia and immune disease. Our analyses provided the strongest evidence of pleiotropy at rs1734907 (∼85kb upstream of <italic toggle="yes">EPHB4</italic>), a variant which was associated with increased risk of both Crohn’s disease (OR = 1.16, P = 1.67×10<sup>−13</sup>) and schizophrenia (OR = 1.07, P = 7.55×10<sup>−6</sup>). Next, we investigated genome-wide sharing of common variants between schizophrenia and immune diseases using polygenic risk scores (PRS) and cross-trait LD Score regression (LDSC). PRS revealed significant genetic overlap with schizophrenia for narcolepsy (p=4.1×10<sup>−4</sup>), primary biliary cirrhosis (p=1.4×10<sup>−8</sup>), psoriasis (p=3.6×10<sup>−5</sup>), systemic lupus erythematosus (p=2.2×10<sup>−8</sup>), and ulcerative colitis (p=4.3×10<sup>−4</sup>). Genetic correlations between these immune diseases and schizophrenia, estimated using LDSC, ranged from 0.10 to 0.18 and were consistent with the expected phenotypic correlation based on epidemiological data. We also observed suggestive evidence of sex-dependent genetic correlation between schizophrenia and multiple sclerosis (interaction p=0.02), with genetic risk scores for multiple sclerosis associated with greater risk of schizophrenia among males but not females. Our findings suggest that shared genetic risk factors contribute to the epidemiological co-occurrence of schizophrenia and certain immune diseases, and suggest that in some cases this genetic correlation is sex-dependent.</p><sec hwp:id="sec-1"><title hwp:id="title-2">Author Summary</title><p hwp:id="p-5">Immune diseases occur at different rates among patients with schizophrenia compared to the general population. While the reasons for this phenotypic correlation are unclear, shared genetic risk (<bold>genetic correlation</bold>) has been proposed as a contributing factor. Prior studies have estimated the genetic correlation between schizophrenia and a handful of immune diseases, with conflicting results. Here, we performed a comprehensive cross-disorder investigation of schizophrenia and 19 immune diseases. We identified three individual genetic variants associated with both schizophrenia and immune diseases, including a variant near <italic toggle="yes">EPHB4</italic> – a gene whose protein product guides the migration of lymphocytes towards infected cells in the immune system and the migration of neuronal axons in the brain. We demonstrated significant genome-wide genetic correlation between schizophrenia and narcolepsy, primary biliary cirrhosis, psoriasis, systemic lupus erythematosus, and ulcerative colitis. Finally, we identified a potential sex-dependent pleiotropic effect between schizophrenia and multiple sclerosis. Our findings point to shared genetic risk for schizophrenia and at least a subset of immune diseases, which likely contributes to their epidemiological co-occurrence. These results raise the possibility that the same genetic variants may exert their effects on neurons or immune cells to influence the development of psychiatric and immune disorders, respectively.</p></sec></abstract><counts><page-count count="47"/></counts><custom-meta-wrap><custom-meta hwp:id="custom-meta-1"><meta-name>special-property</meta-name><meta-value>contains-inline-supplementary-material</meta-value></custom-meta></custom-meta-wrap><custom-meta-wrap>
    <custom-meta hwp:id="custom-meta-2">
      <meta-name>has-earlier-version</meta-name>
      <meta-value>yes</meta-value>
    </custom-meta>
  </custom-meta-wrap></article-meta></front><body><sec id="s1" hwp:id="sec-2"><title hwp:id="title-3">Introduction</title><p hwp:id="p-6">Despite recent advances in identifying key biomarkers and genetic loci for schizophrenia, its pathophysiology remains poorly understood [<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-1" hwp:rel-id="ref-1">1</xref>, <xref rid="c2" ref-type="bibr" hwp:id="xref-ref-2-1" hwp:rel-id="ref-2">2</xref>]. One interesting epidemiological observation is that the risk of developing many immune-mediated diseases is increased among patients with schizophrenia [3–5], and vice versa [<xref rid="c6" ref-type="bibr" hwp:id="xref-ref-6-1" hwp:rel-id="ref-6">6</xref>, <xref rid="c7" ref-type="bibr" hwp:id="xref-ref-7-1" hwp:rel-id="ref-7">7</xref>]. Here, we use the term <bold>immune disease</bold> to broadly encompass both autoimmune and inflammatory disorders. While there are discrepancies among studies regarding which immune diseases are most strongly correlated with schizophrenia, there is converging evidence that these diseases co-occur at a greater rate than is expected by chance [<xref rid="c3" ref-type="bibr" hwp:id="xref-ref-3-1" hwp:rel-id="ref-3">3</xref>–<xref rid="c7" ref-type="bibr" hwp:id="xref-ref-7-2" hwp:rel-id="ref-7">7</xref>]. A notable exception is rheumatoid arthritis (RA), where a consistent inverse association with schizophrenia has been observed [<xref rid="c5" ref-type="bibr" hwp:id="xref-ref-5-1" hwp:rel-id="ref-5">5</xref>, <xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-1" hwp:rel-id="ref-8">8</xref>].</p><p hwp:id="p-7">Genetic factors have long been proposed as an explanation for the differing prevalence of immune diseases among patients with schizophrenia compared to the general population [<xref rid="c5" ref-type="bibr" hwp:id="xref-ref-5-2" hwp:rel-id="ref-5">5</xref>, <xref rid="c6" ref-type="bibr" hwp:id="xref-ref-6-2" hwp:rel-id="ref-6">6</xref>]. The recently reported role of <italic toggle="yes">complement component 4</italic> (<italic toggle="yes">C4</italic>) variation in schizophrenia [<xref rid="c9" ref-type="bibr" hwp:id="xref-ref-9-1" hwp:rel-id="ref-9">9</xref>] illustrates a potential shared genetic mechanism in the development of immune and psychiatric disorders. Genetic variants conferring increased <italic toggle="yes">C4</italic> expression protect against developing systemic lupus erythematosus (SLE), possibly by increased tagging of apoptotic cells – which are the trigger for autoantibody development in SLE – leading to more effective clearance by macrophages [<xref rid="c10" ref-type="bibr" hwp:id="xref-ref-10-1" hwp:rel-id="ref-10">10</xref>]. The same genetic mechanism may increase the risk of developing schizophrenia, by increased tagging of neuronal synapses for elimination by microglia leading to excessive synaptic pruning [<xref rid="c9" ref-type="bibr" hwp:id="xref-ref-9-2" hwp:rel-id="ref-9">9</xref>]. We hypothesize that similar shared genetic mechanisms may occur throughout the genome, with cellular manifestations in immune cells and neurons influencing the development of immune and psychiatric disorders, respectively. Previously, we found that susceptibility to schizophrenia does not appear to be driven by the broad set of loci harboring immune genes [<xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-1" hwp:rel-id="ref-11">11</xref>]. However, not all genetic variants conferring risk of immune disease fall within immune loci. Here, we evaluated whether common genetic variants influencing the risk of 19 different immune diseases may also be involved in schizophrenia.</p><p hwp:id="p-8">Our cross-disorder genetic approach is supported by recent successes in identifying shared genetic risk variants (<bold>pleiotropy</bold>) across a variety of human diseases [<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-1" hwp:rel-id="ref-12">12</xref>–<xref rid="c18" ref-type="bibr" hwp:id="xref-ref-18-1" hwp:rel-id="ref-18">18</xref>]. Pleiotropy is emerging as a pervasive phenomenon in the human genome [<xref rid="c19" ref-type="bibr" hwp:id="xref-ref-19-1" hwp:rel-id="ref-19">19</xref>–<xref rid="c21" ref-type="bibr" hwp:id="xref-ref-21-1" hwp:rel-id="ref-21">21</xref>], and cross-disorder studies characterizing the nature of genotype-phenotype relationships have the potential to yield significant insights into disease etiology. For instance, cross-trait genetic analyses have shed new light on cardiovascular disease and lipid biology – and shifted attention away from HDL as a potential treatment target – by demonstrating that increased HDL cholesterol levels do not reduce the risk of myocardial infarction [<xref rid="c14" ref-type="bibr" hwp:id="xref-ref-14-1" hwp:rel-id="ref-14">14</xref>]. In psychiatry, cross-disorder analyses have identified significant pleiotropy between schizophrenia, bipolar disorder, and major depressive disorder, indicating that these diseases are not as distinct at a pathophysiological level as current diagnostic criteria suggest [<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-2" hwp:rel-id="ref-12">12</xref>, <xref rid="c13" ref-type="bibr" hwp:id="xref-ref-13-1" hwp:rel-id="ref-13">13</xref>, <xref rid="c22" ref-type="bibr" hwp:id="xref-ref-22-1" hwp:rel-id="ref-22">22</xref>].</p><p hwp:id="p-9">While previous studies have investigated genome-wide pleiotropy between schizophrenia and immune disorders, results have been inconsistent (<bold>S1 Table</bold>). Genetic correlation has been reported between schizophrenia and Crohn’s disease [<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-1" hwp:rel-id="ref-23">23</xref>–<xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-1" hwp:rel-id="ref-27">27</xref>], multiple sclerosis [<xref rid="c28" ref-type="bibr" hwp:id="xref-ref-28-1" hwp:rel-id="ref-28">28</xref>], primary biliary cirrhosis [<xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-1" hwp:rel-id="ref-25">25</xref>], psoriasis [<xref rid="c29" ref-type="bibr" hwp:id="xref-ref-29-1" hwp:rel-id="ref-29">29</xref>], rheumatoid arthritis [<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-2" hwp:rel-id="ref-23">23</xref>, <xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-1" hwp:rel-id="ref-24">24</xref>], systemic lupus erythematosus [<xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-2" hwp:rel-id="ref-24">24</xref>, <xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-2" hwp:rel-id="ref-25">25</xref>], and type 1 diabetes [<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-3" hwp:rel-id="ref-23">23</xref>, <xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-3" hwp:rel-id="ref-24">24</xref>, <xref rid="c26" ref-type="bibr" hwp:id="xref-ref-26-1" hwp:rel-id="ref-26">26</xref>, <xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-2" hwp:rel-id="ref-27">27</xref>] in some studies, but not in others [<xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-2" hwp:rel-id="ref-8">8</xref>, <xref rid="c13" ref-type="bibr" hwp:id="xref-ref-13-2" hwp:rel-id="ref-13">13</xref>, <xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-1" hwp:rel-id="ref-16">16</xref>, <xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-4" hwp:rel-id="ref-24">24</xref>, <xref rid="c30" ref-type="bibr" hwp:id="xref-ref-30-1" hwp:rel-id="ref-30">30</xref>]. Interestingly, negative genetic correlation (whereby genetic risk protects against developing schizophrenia) has also been reported for RA [<xref rid="c31" ref-type="bibr" hwp:id="xref-ref-31-1" hwp:rel-id="ref-31">31</xref>], in keeping with the inverse epidemiological association [<xref rid="c5" ref-type="bibr" hwp:id="xref-ref-5-3" hwp:rel-id="ref-5">5</xref>, <xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-3" hwp:rel-id="ref-8">8</xref>].</p><p hwp:id="p-10">Additional studies are needed to reconcile the inconsistencies in existing cross-trait analyses of schizophrenia and immune disorders, with careful attention towards potential confounding variables (e.g. population stratification, linkage disequilibrium, non-independence of genome-wide association study (GWAS) samples, and sex-specific effects). To this end we have performed a comprehensive cross-disorder analysis of schizophrenia and 19 immune diseases, using data from the largest available genetic studies. Our findings add to a growing body of literature supporting pervasive pleiotropy between schizophrenia and immune diseases. We extend existing literature by including 10 immune diseases that have not previously been compared with schizophrenia, prioritizing pleiotropic genes through integrative analyses of multiomics data, estimating how much of the phenotypic correlation between schizophrenia and immune diseases was explained by the genetic correlations we observed, and providing novel evidence for potential sex-specific pleiotropy between schizophrenia and immune disease.</p></sec><sec id="s2" hwp:id="sec-3"><title hwp:id="title-4">Results</title><sec id="s2a" hwp:id="sec-4"><title hwp:id="title-5">Defining immune risk variants</title><p hwp:id="p-11">We identified immune-mediated diseases with robust GWAS findings using ImmunoBase (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.immunobase.org" ext-link-type="uri" xlink:href="http://www.immunobase.org" hwp:id="ext-link-2">http://www.immunobase.org</ext-link>; accessed 7 June 2015), an online resource providing curated GWAS data for immune-related human diseases. These included the following 19 diseases: alopecia areata (AA), ankylosing spondylitis (AS), autoimmune thyroid disease (ATD), celiac disease (CEL), Crohn’s disease (CRO), inflammatory bowel disease (IBD), juvenile idiopathic arthritis (JIA), multiple sclerosis (MS), narcolepsy (NAR), primary biliary cirrhosis (PBC), primary sclerosing cholangitis (PSC), psoriasis (PSO), rheumatoid arthritis (RA), Sjögren’s syndrome (SJO), systemic lupus erythematosus (SLE), systemic sclerosis (SSC), type 1 diabetes (T1D), ulcerative colitis (UC), and vitiligo (VIT). Notably, the majority of IBD risk variants were also risk variants for CRO and/or UC. For 14 of these immune diseases (see <bold><xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-1" hwp:rel-id="T1">Table 1</xref></bold>), we also obtained full GWAS or Immunochip summary statistics allowing us to conduct additional polygenic risk scoring (PRS) [<xref rid="c30" ref-type="bibr" hwp:id="xref-ref-30-2" hwp:rel-id="ref-30">30</xref>, <xref rid="c32" ref-type="bibr" hwp:id="xref-ref-32-1" hwp:rel-id="ref-32">32</xref>] and cross-trait Linkage Disequilibrium Score regression (LDSC) analyses [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-2" hwp:rel-id="ref-16">16</xref>].</p><table-wrap id="tbl1" orientation="portrait" position="float" hwp:id="T1" hwp:rev-id="xref-table-wrap-1-1 xref-table-wrap-1-2 xref-table-wrap-1-3 xref-table-wrap-1-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;068684v3/TBL1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T1</object-id><object-id pub-id-type="publisher-id">tbl1</object-id><label>Table 1.</label><caption hwp:id="caption-1"><p hwp:id="p-12">Description of datasets analyzed</p></caption><graphic xlink:href="068684v3_tbl1" position="float" orientation="portrait" hwp:id="graphic-1"/></table-wrap><p hwp:id="p-13">Given that human leukocyte antigen (HLA) alleles within the major histocompatibility complex (MHC) region (chromosome 6: 25-34 Mb) account for a significant proportion of heritability of immune and inflammatory disorders [<xref rid="c33" ref-type="bibr" hwp:id="xref-ref-33-1" hwp:rel-id="ref-33">33</xref>], we considered HLA and non-HLA risk variants separately in our analyses. Within the MHC region we considered only the most strongly associated HLA variant (including SNPs, imputed HLA amino acid sites, and classical alleles) for each disease based on univariate analysis in previously published studies (see <bold><xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-1" hwp:rel-id="T2">Table 2</xref></bold>), because multivariate conditional analyses reporting adjusted effect sizes of independent HLA variants were not available for all immune diseases. Outside of the MHC region, we considered all non-HLA variants curated in ImmunoBase for each of the 19 immune diseases.</p><table-wrap id="tbl2" orientation="portrait" position="float" hwp:id="T2" hwp:rev-id="xref-table-wrap-2-1 xref-table-wrap-2-2 xref-table-wrap-2-3 xref-table-wrap-2-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;068684v3/TBL2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T2</object-id><object-id pub-id-type="publisher-id">tbl2</object-id><label>Table 2.</label><caption hwp:id="caption-2"><p hwp:id="p-14">Association of top HLA variants for immune diseases in schizophrenia</p></caption><graphic xlink:href="068684v3_tbl2" position="float" orientation="portrait" hwp:id="graphic-2"/></table-wrap><p hwp:id="p-15">The number of genome-wide significant non-HLA risk loci for each of the 19 immune diseases varied from three (NAR) to 144 (IBD). Several variants were associated with more than one immune disease. In total we identified 581 unique variants (563 non-HLA variants and 18 HLA variants) associated with any immune disease at genome-wide significance. We refer to these variants as <bold>immune risk variants</bold>.</p></sec><sec id="s2b" hwp:id="sec-5"><title hwp:id="title-6">Identifying pleiotropic variants implicated in both immune disease and schizophrenia</title><p hwp:id="p-16">First, we evaluated whether there was any evidence of overall risk allele sharing between each of the 19 immune diseases and schizophrenia using a binomial sign test. To do this, we used previously published findings from a GWAS conducted by the Schizophrenia Working Group of the Psychiatric Genomics Consortium [<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-2" hwp:rel-id="ref-1">1</xref>, <xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-2" hwp:rel-id="ref-11">11</xref>]. This GWAS represented a meta-analysis of 52 cohorts, comprising a total of 35,476 cases and 46,839 controls, and the full dataset is referred to here as the <bold>PGC2 study</bold>. Overall, the direction of effect for the sets of non-HLA SNPs associated with each of the 19 immune diseases at genome-wide significance was not shared with schizophrenia more than expected by chance (all binomial sign test p&gt;0.05, <bold>S1 Fig</bold>). Thus, we did not observe evidence of risk allele sharing between any immune disease and schizophrenia when using a stringent genome-wide significance threshold to define immune risk variants. We also evaluated the collective association of 261 LD-independent, non-HLA immune risk variants associated with at least one of the 19 immune-mediated diseases, for which linkage disequilibrium (LD) Score and minor allele frequency (MAF) information were available in the European LD Score database [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-3" hwp:rel-id="ref-16">16</xref>]. We found significant deviation from the theoretical null in schizophrenia for immune risk SNPs (λ=1.46). However, when we compared the association of immune risk SNPs to that of similar randomly selected SNP sets (<bold>Supplementary Methods</bold>) we observed no evidence of enrichment (<bold>S2 Fig</bold>, p=0.66), indicating that immune risk SNPs were not associated with schizophrenia more than expected by chance given the polygenic nature of schizophrenia.</p><p hwp:id="p-17">Next, we identified potential pleiotropic variants by evaluating the association of individual immune risk variants with schizophrenia. We considered SNPs associated with schizophrenia at p&lt;8.6×10<sup>−5</sup> (Bonferroni correction for 581 tests, 563 non-HLA and 18 HLA variants) to have pleiotropic effects. Given the size of the schizophrenia GWAS, we had over 80% power to detect pleiotropic SNPs assuming an OR≥1.12 in schizophrenia.</p><p hwp:id="p-18">Within the MHC region, we observed four HLA risk alleles associated with both immune disease and schizophrenia, particularly in the class II HLA region (<bold><xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-2" hwp:rel-id="T2">Table 2</xref>, S3 Fig</bold>). These HLA risk alleles were the strongest MHC region associations for AA (HLA-DRB1 #37 Asn), CEL (HLA-DQB1 #74 Ala), PSC (HLA-B*08:01), and SJO (HLA-DQB1*02:01). The presence of HLA-DRB1 #37 Asn conferred a protective association in both AA and schizophrenia, but the remaining HLA variants showed the opposite direction of effect in schizophrenia compared to immune disease (<bold><xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-3" hwp:rel-id="T2">Table 2</xref></bold>, <bold>S3 Fig</bold>). Notably, none of these four HLA variants were significantly associated with schizophrenia in previous conditional analyses [<xref rid="c9" ref-type="bibr" hwp:id="xref-ref-9-3" hwp:rel-id="ref-9">9</xref>, <xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-3" hwp:rel-id="ref-11">11</xref>], suggesting that their association with schizophrenia may be driven by LD with other causal variants in the region rather than true pleiotropy. Thus, we did not focus additional analyses on these variants.</p><p hwp:id="p-19">Outside of the MHC region, five immune risk variants showed potential pleiotropic effects, with the risk allele for immune disease also conferring risk for schizophrenia. These variants have been previously implicated in CRO (rs6738825, rs13126505, rs1734907 [<xref rid="c34" ref-type="bibr" hwp:id="xref-ref-34-1" hwp:rel-id="ref-34">34</xref>, <xref rid="c35" ref-type="bibr" hwp:id="xref-ref-35-1" hwp:rel-id="ref-35">35</xref>]), MS (rs7132277 [<xref rid="c36" ref-type="bibr" hwp:id="xref-ref-36-1" hwp:rel-id="ref-36">36</xref>]), and CEL (rs296547 [<xref rid="c37" ref-type="bibr" hwp:id="xref-ref-37-1" hwp:rel-id="ref-37">37</xref>]). To evaluate the pleiotropic potential of these non-HLA variants, we used conditional and joint analysis (COJO) [<xref rid="c38" ref-type="bibr" hwp:id="xref-ref-38-1" hwp:rel-id="ref-38">38</xref>] to perform association analyses in the PGC2 schizophrenia GWAS conditioning on each of the five immune risk variants (<bold>S4 Fig</bold>). In the setting of true pleiotropy, no significant associations should remain after conditioning on the immune risk variants (statistically, all p&gt;8.6×10<sup>−5</sup>). Consistent with pleiotropy, we observed no remaining associations with schizophrenia after conditioning on rs296547 (top SNP after conditioning: rs111530734, p=1.19×10<sup>−3</sup>), rs1734907 (top SNP after conditioning: rs11768688, p=9.79×10<sup>−4</sup>), and rs13126505 (top SNP after conditioning: rs112786981, p=4.58×10<sup>−4</sup>). Significant associations with schizophrenia remained after conditioning on rs6738825 (top SNP after conditioning: rs111744017, p=8.03×10<sup>−6</sup>) and rs7132277 (top SNP after conditioning: rs74240770, p=1.37×10<sup>−8</sup>), suggesting there were independent causal variants driving the associations in these regions for schizophrenia and immune disorders.</p><p hwp:id="p-20">In order to prioritize genes underlying the identified pleiotropic SNPs (rs296547, rs1734907, rs13126505), we performed an integrative analysis of GWAS summary statistics with methylation quantitative trait loci (mQTL) and expression quantitative trait loci (eQTL) studies using SMR and HEIDI [<xref rid="c39" ref-type="bibr" hwp:id="xref-ref-39-1" hwp:rel-id="ref-39">39</xref>, <xref rid="c40" ref-type="bibr" hwp:id="xref-ref-40-1" hwp:rel-id="ref-40">40</xref>] (<bold>Materials and Methods</bold>). Notably, rs296547 was not genotyped in the eQTL dataset, and we used rs404339 as a proxy SNP (r<sup>2</sup>=0.85 in 1000 Genomes Phase 3 CEU Population [<xref rid="c41" ref-type="bibr" hwp:id="xref-ref-41-1" hwp:rel-id="ref-41">41</xref>]) in SMR analyses of gene expression analyses for rs296547. We observed that rs1734907 was an mQTL (β = 0.47, P = 2.13×10<sup>−26</sup>) and eQTL (β = −0.24, P = 3.54×10<sup>−10</sup>) for <italic toggle="yes">EPHB4</italic> in peripheral blood (<bold>S2 Table, <xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-1" hwp:rel-id="F1">Fig 1</xref></bold>). Furthermore, we observed consistent pleiotropic associations for rs1734907 with schizophrenia and <italic toggle="yes">EPHB4</italic> DNAm (β<sub>SMR</sub> = −0.14, P<sub>SMR</sub> = 3.58×10<sup>−5</sup>, P<sub>HEIDI</sub> = 0.12), schizophrenia and <italic toggle="yes">EPHB4</italic> expression (β<sub>SMR</sub> = −0.28, P<sub>SMR</sub> = 2.63×10<sup>−4</sup>, P<sub>HEIDI</sub> = 0.17), and <italic toggle="yes">EPHB4</italic> DNAm and <italic toggle="yes">EPHB4</italic> expression (β<sub>SMR</sub> = 1.98, P<sub>SMR</sub> = 6.56×10<sup>−8</sup>, P<sub>HEIDI</sub> = 0.011). Thus, there was consistent association across molecular phenotypes and schizophrenia at the <italic toggle="yes">EPHB4</italic> locus, suggesting this gene may be driving the association of rs1734907 in schizophrenia (<bold><xref rid="fig1" ref-type="fig" hwp:id="xref-fig-1-2" hwp:rel-id="F1">Fig 1</xref></bold>). Notably,<italic toggle="yes">TRIP6</italic> is also a candidate functional gene underlying the association of rs1734907 with schizophrenia. We observed pleiotropic association for rs1734907 with schizophrenia and <italic toggle="yes">TRIP6</italic> DNAm with inconsistent direction of effect (β<sub>SMR</sub> = 0.15, P<sub>SMR</sub> = 5.00×10<sup>−5</sup>, P<sub>HEIDI</sub> = 0.17 for probe cg18683606; β<sub>SMR</sub> = - 0.12, P<sub>SMR</sub> = 2.32×10<sup>−5</sup>, P<sub>HEIDI</sub> = 0.18 for probe cg27396824), a trend for association with schizophrenia and <italic toggle="yes">TRIP6</italic> expression (β<sub>SMR</sub> = −0.33, P<sub>SMR</sub> = 6.38×10<sup>−4</sup>, P<sub>HEIDI</sub> = 0.14), but no significant association with <italic toggle="yes">TRIP6</italic> DNAm and <italic toggle="yes">TRIP6</italic> expression. The other pleiotropic SNPs (rs296547, rs13126505) did not demonstrate consistent localization to a particular gene across traits and molecular phenotypes (<bold><xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-1" hwp:rel-id="T3">Table 3</xref>, S2 Table</bold>). We observed that rs296547 was an mQTL for <italic toggle="yes">C1orf106</italic> (β = −1.04, P &lt; 10<sup>−30</sup>), and found pleiotropic associations for rs296547 with schizophrenia and <italic toggle="yes">C1orf106</italic> DNAm but no other phenotypes (<bold><xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-2" hwp:rel-id="T3">Table 3</xref>, S2 Table</bold>). Similarly, we observed that rs13126505 was an mQTL (β = 0.49, P = 4.03×10<sup>−16</sup>) and eQTL (β = −0.27, P = 3.54×10<sup>−10</sup>) for S<italic toggle="yes">LC39A8</italic>, and found pleiotropic associations for rs13126505 with schizophrenia and <italic toggle="yes">SLC39A8</italic> DNAm along with schizophrenia and <italic toggle="yes">SLC39A8</italic> expression, but not <italic toggle="yes">SLC39A8</italic> DNAm and expression (<bold><xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-3" hwp:rel-id="T3">Table 3</xref>, S2 Table</bold>).</p><table-wrap id="tbl3" orientation="portrait" position="float" hwp:id="T3" hwp:rev-id="xref-table-wrap-3-1 xref-table-wrap-3-2 xref-table-wrap-3-3 xref-table-wrap-3-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;068684v3/TBL3</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T3</object-id><object-id pub-id-type="publisher-id">tbl3</object-id><label>Table 3.</label><caption hwp:id="caption-3"><p hwp:id="p-21">Immune disease risk SNPs showing pleiotropic effect in schizophrenia</p></caption><graphic xlink:href="068684v3_tbl3" position="float" orientation="portrait" hwp:id="graphic-3"/></table-wrap><fig id="fig1" position="float" fig-type="figure" orientation="portrait" hwp:id="F1" hwp:rev-id="xref-fig-1-1 xref-fig-1-2"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;068684v3/FIG1</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F1</object-id><object-id pub-id-type="publisher-id">fig1</object-id><label>Fig 1.</label><caption hwp:id="caption-4"><title hwp:id="title-7">Prioritizing genes driving the pleiotropic association of rs1734907 in Crohn’s disease and schizophrenia</title><p hwp:id="p-22">Associations for SNP and SMR analyses across GWAS, eQTL, and mQTL datasets. Top plot gray circles illustrate SNP association (-log<sub>10</sub> p-value) with schizophrenia in the PGC-2 GWAS, while pink diamonds and blue circles indicate results of SMR tests (-log<sub>10</sub> p-value) for association of gene expression and DNAm with schizophrenia, respectively, with solid shading indicating probes passing the HEIDI test. Middle plot illustrates SNP association (-log<sub>10</sub> p-value) with gene expression from peripheral blood eQTL dataset. Lower plots illustrate SNP association (-log<sub>10</sub> p-value) with gene methylation from peripheral blood mQTL dataset.</p></caption><graphic xlink:href="068684v3_fig1" position="float" orientation="portrait" hwp:id="graphic-4"/></fig></sec><sec id="s2c" hwp:id="sec-6"><title hwp:id="title-8">Detecting genetic correlations between immune disease and schizophrenia</title><p hwp:id="p-23">Our immune risk variant set captured only those variants associated with immune diseases at genome-wide significance in current GWASs. Given the polygenicity of immune-related diseases, there are 100s to 1,000s of additional variants associated with each disease which have not yet been identified [<xref rid="c42" ref-type="bibr" hwp:id="xref-ref-42-1" hwp:rel-id="ref-42">42</xref>]. To evaluate sharing of risk alleles between immune diseases and schizophrenia using a broader set of variants, we used PRS [<xref rid="c30" ref-type="bibr" hwp:id="xref-ref-30-3" hwp:rel-id="ref-30">30</xref>, <xref rid="c32" ref-type="bibr" hwp:id="xref-ref-32-2" hwp:rel-id="ref-32">32</xref>] and LDSC [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-4" hwp:rel-id="ref-16">16</xref>].</p><p hwp:id="p-24">For each of the 14 immune diseases with available genome-wide summary statistics, we constructed genetic risk scores (GRSs) at a range of p-value thresholds (p<sub>T</sub>) as in previous studies [<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-3" hwp:rel-id="ref-12">12</xref>], and tested for the association of these GRSs with schizophrenia in a refined subset of the PGC2 study (17,000 cases and 20,655 controls) which excluded samples shared with the immune disease GWASs. To benchmark our findings in immune diseases, we also analyzed human height [<xref rid="c43" ref-type="bibr" hwp:id="xref-ref-43-1" hwp:rel-id="ref-43">43</xref>] and included previously published PRS results for bipolar disorder [<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-4" hwp:rel-id="ref-12">12</xref>]. We considered immune diseases with PRS p&lt;0.002 at any p<sub>T</sub> to show significant genetic overlap with schizophrenia (Bonferroni correction for 14 immune diseases tested in both sexes, 0.05/(14*2) ≈ 0.002). Commonly used goodness-of-fit estimates obtained from PRS (such as <italic toggle="yes">β</italic><sub>GRS</sub> and Nagelkerke’s pseudo-R<sup>2</sup>) lack meaningful interpretation, which makes it difficult to compare these estimates across studies [<xref rid="c44" ref-type="bibr" hwp:id="xref-ref-44-1" hwp:rel-id="ref-44">44</xref>]. For these reasons we chose to interpret the direction of effect (i.e. positive or negative correlation) obtained from <italic toggle="yes">β</italic><sub>GRS</sub>, but not to interpret or compare the degree of genetic sharing between immune diseases and schizophrenia. For further details of our PRS approach, see <bold>Materials and Methods</bold>. Using PRS, we had over 80% power to detect genetic covariance with schizophrenia ranging from 0.02 to 0.03 for most of the immune diseases, although some showed less than 80% power in this range (PSO, SLE, VIT; <bold>S5 Fig</bold>).</p><p hwp:id="p-25">As previously described, bipolar disorder PRSs were significantly associated with schizophrenia (p&lt;1×10<sup>−50</sup> at p<sub>T</sub>&lt;1) [<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-5" hwp:rel-id="ref-12">12</xref>]. Surprisingly, human height PRSs were also significantly associated with schizophrenia (p=1×10<sup>−11</sup> at p<sub>T</sub>&lt;1, <bold>S3 Table</bold>). Height was analyzed as a negative control based on its previously reported lack of genetic correlation with schizophrenia using LDSC [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-5" hwp:rel-id="ref-16">16</xref>]. Using PRS, we observed that genetic liability for increased height protected against schizophrenia (β<sub>GRS</sub>=-0.11 at p<sub>T</sub>&lt;1). The significant inverse association of height PRSs with schizophrenia case-status we observed may reflect the greater sensitivity of this approach to subtle population stratification, sample sharing, and/or true genetic overlap.</p><p hwp:id="p-26">Genetic scores including the HLA region were significant for CEL, NAR, PBC, PSO, RA, SLE, SSC, T1D, and UC (p&lt;0.002 at multiple p<sub>T</sub>, <bold>S4 Table</bold>). Height was not included in these analyses, given that HLA variants have not been associated with height in previous GWAS [<xref rid="c43" ref-type="bibr" hwp:id="xref-ref-43-2" hwp:rel-id="ref-43">43</xref>]. With the exception of CEL (β<sub>GRS</sub> ≈ 0.04 at p<sub>T</sub>&lt;5×10<sup>−8</sup>, 1×10<sup>−4</sup>, and 1×10<sup>−3</sup>), all immune diseases exhibited a positively associated PRS with schizophrenia case-status (all β<sub>GRS</sub>&gt;0, <bold>S4 Table</bold>). For CEL, RA, SLE, and SSC only those PRSs constructed using the most stringent p-value cutoffs (5×10<sup>−8</sup>, 1×10<sup>−4</sup>, 1×10<sup>−3</sup>) were significantly associated with schizophrenia. To evaluate whether the HLA region alone was driving the observed genetic sharing, we constructed PRSs excluding this region. After excluding HLA variants, genetic scores for NAR, PBC, PSO, SLE, T1D, and UC remained significantly associated with schizophrenia (<bold><xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-1" hwp:rel-id="T4">Table 4</xref>, S6 Fig</bold>). Because the genetic overlap between these six immune diseases and schizophrenia was not driven by a single HLA variant of large effect, we focused on these findings for the remainder of our analyses.</p><table-wrap id="tbl4" orientation="portrait" position="float" hwp:id="T4" hwp:rev-id="xref-table-wrap-4-1 xref-table-wrap-4-2 xref-table-wrap-4-3 xref-table-wrap-4-4 xref-table-wrap-4-5 xref-table-wrap-4-6"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;068684v3/TBL4</object-id><object-id pub-id-type="other" hwp:sub-type="slug">T4</object-id><object-id pub-id-type="publisher-id">tbl4</object-id><label>Table 4.</label><caption hwp:id="caption-5"><p hwp:id="p-27">Estimated phenotypic and genome-wide genetic correlations between schizophrenia and other traits</p></caption><graphic xlink:href="068684v3_tbl4" position="float" orientation="portrait" hwp:id="graphic-5"/></table-wrap><p hwp:id="p-28">Given the potential sensitivity of PRS to artificial genetic overlap highlighted in our analysis of height, we wanted to assess whether cryptic sample sharing between the immune and schizophrenia GWASs could be driving the shared genetic liability that we observed. To do this, we conducted leave-half-out analyses. If the observed genetic overlap was driven by samples shared between certain schizophrenia cohorts and the immune disease GWASs, the GRS association should not be consistently observed across subsamples leaving out half of the schizophrenia cohorts. Across 1,000 subsamples (N<sub>cases</sub> ranging from 3,985-13,074) leaving out a randomly selected 14 cohorts, we observed a high proportion of subsamples with GRSs significantly associated with schizophrenia (p&lt;0.05 at p<sub>T</sub>&lt;1) for height (0.99), NAR (0.72), PBC (0.95), PSO (0.84), SLE (0.97), T1D (0.95), and UC (0.70) suggesting our findings were not driven by sample sharing.</p><p hwp:id="p-29">To further validate our finding of genetic overlap between schizophrenia and these six immune-mediated diseases using PRS, we applied an independent method (LDSC) for estimating genome-wide genetic correlation between traits that is robust to sample sharing [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-6" hwp:rel-id="ref-16">16</xref>]. For LDSC analyses, we used summary statistics from the 49 European-ancestry cohorts in the PGC2 study (31,335 cases and 38,765 controls) [<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-3" hwp:rel-id="ref-1">1</xref>]. Unlike PRS, LDSC provides an interpretable and comparable estimation of genetic sharing between two traits in the form of genetic correlation (r<sub>g</sub>) values. Notably, LDSC is less sensitive than PRS and is not robust when applied to genetic data obtained from specialty chips (e.g. Immunochip) [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-7" hwp:rel-id="ref-16">16</xref>]. We did not carry T1D forward for LDSC analysis, due to failure of this dataset on quality control measures (liability scale h<sup>2</sup> &gt;1, likely secondary to inflated effective sample size due to genotyping on Immunochip). Given that this was a secondary analysis, we considered immune diseases with r<sub>g</sub> p&lt;0.05 to show significant genetic overlap with schizophrenia.</p><p hwp:id="p-30">As previously reported [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-8" hwp:rel-id="ref-16">16</xref>], our positive control (bipolar disorder) showed significant genetic overlap with schizophrenia (r<sub>g</sub>=0.75±0.05, p=8.5×10<sup>−60</sup>; <bold><xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-1" hwp:rel-id="F2">Fig 2</xref>, <xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-2" hwp:rel-id="T4">Table 4</xref></bold>). In contrast to our PRS results, but in agreement with previous findings [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-9" hwp:rel-id="ref-16">16</xref>], our negative control (height) showed no such overlap using LDSC (r<sub>g</sub>=-0.004±0.02, p=0.84; <bold><xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-2" hwp:rel-id="F2">Fig 2</xref></bold>, <bold><xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-3" hwp:rel-id="T4">Table 4</xref></bold>). With respect to immune diseases, LDSC confirmed significant genetic overlap with schizophrenia for PBC, PSO, SLE, and UC (r<sub>g</sub>=0.10-0.18, <bold><xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-3" hwp:rel-id="F2">Fig 2</xref></bold>, <bold><xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-4" hwp:rel-id="T4">Table 4</xref></bold>) indicating the association of GRSs for these diseases was not driven by shared samples. Notably, genetic correlations for PSO and SLE did not survive correction for the 14 tests performed (<bold><xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-5" hwp:rel-id="T4">Table 4</xref></bold>). We also observed significant genetic overlap with schizophrenia for NAR using LDSC, with the caveat that this dataset was genotyped using Immunochip and did not survive multiple testing correction (<bold><xref rid="fig2" ref-type="fig" hwp:id="xref-fig-2-4" hwp:rel-id="F2">Fig 2</xref></bold>, <bold><xref rid="tbl4" ref-type="table" hwp:id="xref-table-wrap-4-6" hwp:rel-id="T4">Table 4</xref></bold>). Overall, LDSC provided consistent results for the immune diseases showing significant genetic sharing with schizophrenia by PRS.</p><fig id="fig2" position="float" fig-type="figure" orientation="portrait" hwp:id="F2" hwp:rev-id="xref-fig-2-1 xref-fig-2-2 xref-fig-2-3 xref-fig-2-4"><object-id pub-id-type="other" hwp:sub-type="pisa">biorxiv;068684v3/FIG2</object-id><object-id pub-id-type="other" hwp:sub-type="slug">F2</object-id><object-id pub-id-type="publisher-id">fig2</object-id><label>Fig 2.</label><caption hwp:id="caption-6"><title hwp:id="title-9">Genetic correlation between schizophrenia and other traits</title><p hwp:id="p-31">Genetic correlation between schizophrenia, bipolar disorder, height, and 14 immune diseases was estimated using cross-trait LDSC [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-10" hwp:rel-id="ref-16">16</xref>]. Colour of square indicates strength of genetic correlation (red, negative correlation; blue, positive correlation). Size of square indicates statistical significance (larger, more significant <italic toggle="yes">p</italic>-value). Asterisks indicate genetic correlations that are statistically significant at <italic toggle="yes">p</italic> &lt; 0.05 threshold. BP, bipolar disorder; CEL, celiac disease; CRO, Crohn’s disease; HGT, height; IBD, inflammatory bowel disease; JIA, juvenile idiopathic arthritis; MS, multiple sclerosis; NAR, narcolepsy; PBC, primary biliary cirrhosis; PSO, psoriasis, RA, rheumatoid arthritis; SLE, systemic lupus erythematosus; SSC, systemic sclerosis; T1D, type 1 diabetes; UC, ulcerative colitis; VIT, vitiligo.</p></caption><graphic xlink:href="068684v3_fig2" position="float" orientation="portrait" hwp:id="graphic-6"/></fig></sec><sec id="s2d" hwp:id="sec-7"><title hwp:id="title-10">Benchmarking genetic correlations between immune disease and schizophrenia with epidemiological data</title><p hwp:id="p-32">To determine how much of the phenotypic correlation between schizophrenia and immune-mediated diseases was explained by the genetic correlations we observed, we benchmarked significant genetic correlations between schizophrenia and immune-mediated disorders relative to the expected phenotypic correlations from epidemiological data (<bold>Materials and Methods</bold>). Using incidence of immune diseases in schizophrenia reported in a large population-based study [<xref rid="c3" ref-type="bibr" hwp:id="xref-ref-3-2" hwp:rel-id="ref-3">3</xref>], we estimated phenotypic correlations between schizophrenia and PBC, PSO, SLE, and UC. We were unable to estimate phenotypic correlation for NAR and schizophrenia, given that there were no estimates in the literature of the incidence of NAR in schizophrenia. For PBC, PSO, and SLE we observed small positive genetic correlations with schizophrenia that were consistent with the epidemiological data (PBC: r<sub>g</sub> = 0.131 ± 0.05, r<sub>p</sub> = 0.112; PSO: r<sub>g</sub> = 0.182 ± 0.07, r<sub>p</sub> = 0.130; SLE: r<sub>g</sub> = 0.130 ± 0.05, r<sub>p</sub> = 0.048). For UC we observed a small positive estimate of genetic correlation (r<sub>g</sub> = 0.106 ± 0.04) while there was no strong evidence for any correlation between UC and schizophrenia in the epidemiological data (r<sub>p</sub> = −0.001). Importantly, while the MHC region contains risk factors for both schizophrenia and immune-mediated diseases, our genetic correlation estimates were obtained considering only SNPs outside of the MHC region due to unusual LD in this region [<xref rid="c45" ref-type="bibr" hwp:id="xref-ref-45-1" hwp:rel-id="ref-45">45</xref>].</p></sec><sec id="s2e" hwp:id="sec-8"><title hwp:id="title-11">Exploring sex-dependent genetic correlations between immune disease and schizophrenia</title><p hwp:id="p-33">Given the significant sex bias of autoimmune diseases, with women at greater risk overall [<xref rid="c46" ref-type="bibr" hwp:id="xref-ref-46-1" hwp:rel-id="ref-46">46</xref>], we hypothesized that there may be sex-dependent genetic overlap between schizophrenia and some immune-mediated diseases. We therefore performed sex-stratified PRS, testing the association of height and immune disease GRSs with schizophrenia separately in males and females of the PGC2 study. Genetic scores for height showed significant association with schizophrenia in both males and females. Three of the immune diseases (PBC, PSO, T1D) with significant main effects showed sex-dependent effects, with greater signal among males (<bold>S5 Table</bold>). Additionally, although genetic scores for MS were not significantly associated with schizophrenia in the total sample there was significant association among males (R<sup>2</sup>=0.03, p=1.26×10<sup>−3</sup> at p<sub>T</sub>&lt;1; <bold>S5 Table</bold>).</p><p hwp:id="p-34">Given the greater statistical power for the male subset of the schizophrenia GWAS, we performed simulations by selecting random subsamples of male cases and controls equal in size to the female sample (5,321 cases and 9,094 controls). If the stronger genetic overlap between schizophrenia and MS, PBC, PSO, and T1D among males was driven by the larger sample size rather than a true sex-dependent effect, there should be no consistent association of GRSs with schizophrenia in these subsamples. Across 1,000 subsamples, the proportion with significant GRSs (p&lt;0.002 at p<sub>T</sub>&lt;1) was high for PBC (0.94) and T1D (0.87), suggesting our finding of a greater pleiotropic effect among males for these diseases was not driven solely by lower statistical power among females; this was not the case for PSO (0.59) or MS (0.21).</p><p hwp:id="p-35">Next, we performed formal statistical tests for an interaction between sex and genetic scores for these four immune diseases. We observed a nominally significant interaction for MS (p&lt;0.05 at several p<sub>T</sub>; <bold>S5 Table</bold>), noting that this finding did not survive correction for multiple testing. The remaining immune diseases did not show significant sex interactions, although the direction of effect was consistent with a greater pleiotropic effect in males (<bold>S5 Table</bold>).</p></sec></sec><sec id="s3" hwp:id="sec-9"><title hwp:id="title-12">Discussion</title><p hwp:id="p-36">Using a variety of statistical approaches, we provide evidence of shared genetic risk for schizophrenia and several immune diseases. Within the MHC region, we identified four HLA variants showing statistically significant association with schizophrenia. An important caveat is that these four variants were not the top variants in their respective regions of association with schizophrenia, and were not primary drivers of the MHC association in schizophrenia in stepwise conditional analyses [<xref rid="c9" ref-type="bibr" hwp:id="xref-ref-9-4" hwp:rel-id="ref-9">9</xref>]. Therefore, the biological significance of these particular HLA variants in schizophrenia is likely limited.</p><p hwp:id="p-37">Outside of the MHC region, we identified three SNPs with pleiotropic effects - influencing risk for both celiac disease (CEL) (rs296547) or Crohn’s disease (CRO) (rs1734907, rs13126505) and schizophrenia. Integration of GWAS, mQTL, and eQTL data implicated <italic toggle="yes">C1orf106, SLC39A8</italic>, and <italic toggle="yes">EPHB4</italic> or <italic toggle="yes">TRIP6</italic> as functional candidates driving the pleiotropic association of rs296547, rs13126505, and rs1734907, respectively. Overall, our findings provide the strongest evidence for a model in which genetic variation at rs1734907 (∼85kb upstream of <italic toggle="yes">EPHB4</italic>) increases DNA methylation, upregulates <italic toggle="yes">EPHB4</italic> expression, and decreases the risk of schizophrenia. While DNA methylation is classically associated with gene silencing, the effect of methylation on transcription depends on the genomic context [<xref rid="c47" ref-type="bibr" hwp:id="xref-ref-47-1" hwp:rel-id="ref-47">47</xref>]; for instance, methylation of silencers or insulators eliminates transcription-blocking activity thereby promoting gene expression [<xref rid="c48" ref-type="bibr" hwp:id="xref-ref-48-1" hwp:rel-id="ref-48">48</xref>, <xref rid="c49" ref-type="bibr" hwp:id="xref-ref-49-1" hwp:rel-id="ref-49">49</xref>]. <italic toggle="yes">EPHB4</italic> is a transmembrane tyrosine kinase receptor that coordinates cell movement via bidirectional intercellular signaling at sites of direct cell-to-cell contact [<xref rid="c50" ref-type="bibr" hwp:id="xref-ref-50-1" hwp:rel-id="ref-50">50</xref>]. In the brain, ephrin signaling mediates synaptic plasticity by initiating and stabilizing neuronal synapse formation (reviewed by [<xref rid="c51" ref-type="bibr" hwp:id="xref-ref-51-1" hwp:rel-id="ref-51">51</xref>]). An analogous role has not yet been discovered in the immune system, possibly due to the much shorter lifespan of immunological synapses between lymphocytes and antigen presenting cells (minutes) as compared to neuronal synapses (years) [<xref rid="c52" ref-type="bibr" hwp:id="xref-ref-52-1" hwp:rel-id="ref-52">52</xref>, <xref rid="c53" ref-type="bibr" hwp:id="xref-ref-53-1" hwp:rel-id="ref-53">53</xref>]. Interestingly, ephrin signaling attenuates the migration responses of both neurons and immune cells toward chemoattractants <italic toggle="yes">in vitro</italic> [<xref rid="c54" ref-type="bibr" hwp:id="xref-ref-54-1" hwp:rel-id="ref-54">54</xref>, <xref rid="c55" ref-type="bibr" hwp:id="xref-ref-55-1" hwp:rel-id="ref-55">55</xref>]. Thus, disrupted pathfinding may be a shared risk mechanism by which <italic toggle="yes">EPHB4</italic> contributes to immune disease and schizophrenia. The hypotheses raised by our findings require further validation. If the association of rs1734907 with CRO and schizophrenia is robustly replicated in future GWASs, functional studies will be needed to investigate both the genetic mechanism by which rs1734907 (or a causal variant in LD with this SNP) influences <italic toggle="yes">EPHB4</italic> transcription, and the biological mechanism by which increased <italic toggle="yes">EPHB4</italic> expression influences susceptibility to CRO and schizophrenia. With the multi-kinase inhibitor dasatinib already on the market for treatment of chronic myeloid leukemia [<xref rid="c56" ref-type="bibr" hwp:id="xref-ref-56-1" hwp:rel-id="ref-56">56</xref>] and other EphB4 inhibitors currently in Phase II trials [<xref rid="c57" ref-type="bibr" hwp:id="xref-ref-57-1" hwp:rel-id="ref-57">57</xref>–<xref rid="c60" ref-type="bibr" hwp:id="xref-ref-60-1" hwp:rel-id="ref-60">60</xref>], the potential for future drug repurposing makes <italic toggle="yes">EPHB4</italic> an attractive candidate for further investigation.</p><p hwp:id="p-38">We observed genome-wide sharing of risk variants for schizophrenia and six immune diseases (narcolepsy (NAR), primary biliary cirrhosis (PBC), psoriasis (PSO), systemic lupus erythematosus (SLE), type 1 diabetes (T1D), and ulcerative colitis (UC)) using PRS, all of which have been previously reported to co-occur with schizophrenia in epidemiological studies [<xref rid="c3" ref-type="bibr" hwp:id="xref-ref-3-3" hwp:rel-id="ref-3">3</xref>, <xref rid="c5" ref-type="bibr" hwp:id="xref-ref-5-4" hwp:rel-id="ref-5">5</xref>, <xref rid="c61" ref-type="bibr" hwp:id="xref-ref-61-1" hwp:rel-id="ref-61">61</xref>]. The strongest evidence of shared genetic risk emerged for PBC, PSO, SLE, and UC, which also showed robust genetic correlation with schizophrenia using LDSC. With the exception of UC, the small positive genetic correlations observed between these immune diseases and schizophrenia (r<sub>g</sub> ∼ 0.1) were consistent with phenotypic correlations observed in epidemiological data. Thus, currently available genetic data suggest that shared genetic risk contributes to the co-occurrence of PBC, PSO, and SLE in schizophrenia. Possible explanations for this sharing of genetic risk include the presence of a subgroup of “autoimmune-like” schizophrenia cases and/or sharing of specific biological pathways between schizophrenia and these particular immune diseases.</p><p hwp:id="p-39">To our knowledge, this is the first time that sex-dependent genetic correlation with immune diseases has been investigated in schizophrenia. We found nominal evidence of male-specific genetic correlation for multiple sclerosis (MS), and a stronger pleiotropic effect among males for PBC, PSO, and T1D although the latter were not statistically significant. Interestingly, animal studies indicate that sex hormones have opposing effects on predisposition to schizophrenia and autoimmunity; estrogen has been reported to protect against the development of schizophrenia [<xref rid="c62" ref-type="bibr" hwp:id="xref-ref-62-1" hwp:rel-id="ref-62">62</xref>], while androgens appear to protect against the development autoimmune diseases [<xref rid="c63" ref-type="bibr" hwp:id="xref-ref-63-1" hwp:rel-id="ref-63">63</xref>, <xref rid="c64" ref-type="bibr" hwp:id="xref-ref-64-1" hwp:rel-id="ref-64">64</xref>]. We emphasize that our sex-dependent findings require validation in independent samples. If replicated, one possibility is that sex hormones modulate pathogenesis among genetically vulnerable individuals, making males more likely to develop schizophrenia and females more likely to develop autoimmune diseases.</p><p hwp:id="p-40">Our work was subject to several important limitations. Firstly, genome-wide summary statistics were not available for all of the immune diseases, resulting in a more limited analysis of 14 diseases. For five of these diseases (CEL, juvenile idiopathic arthritis (JIA), MS, NAR, T1D) summary statistics were obtained from Immunochip rather than GWAS, providing incomplete coverage of the genome for comparison with schizophrenia and biasing the genetic correlation estimates obtained by LDSC. Secondly, GRSs for human height – analyzed as a negative control – showed stronger association with schizophrenia than any of the immune diseases. An inverse epidemiological relationship between height and schizophrenia has been reported [<xref rid="c65" ref-type="bibr" hwp:id="xref-ref-65-1" hwp:rel-id="ref-65">65</xref>, <xref rid="c66" ref-type="bibr" hwp:id="xref-ref-66-1" hwp:rel-id="ref-66">66</xref>], consistent with our PRS findings. The reasons for the discrepancy between PRS and LDSC, which showed no genetic correlation between height and schizophrenia (as previously reported [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-11" hwp:rel-id="ref-16">16</xref>]) are unclear. One explanation is that PRS, which uses individual-level genotype data as opposed to summary statistics, is a more sensitive method to detect true genome-wide sharing of risk alleles. If this is the case, it raises a broader question regarding how much genetic overlap is expected across complex traits in general using the PRS approach. Recent work suggests that pleiotropy is pervasive across human diseases, and that this phenomenon is driven at least in part by the polygenic nature of complex traits [<xref rid="c21" ref-type="bibr" hwp:id="xref-ref-21-2" hwp:rel-id="ref-21">21</xref>]. If this is the case, the extreme polygenicity of human height (more than 100,000 common variants estimated to exert independent causal effects [<xref rid="c67" ref-type="bibr" hwp:id="xref-ref-67-1" hwp:rel-id="ref-67">67</xref>]) may be driving the pleiotropy we observed between height and schizophrenia using PRS. An alternative explanation that must be considered is that PRS may be more vulnerable to confounding by cryptic population stratification, LD, or sample sharing.</p><p hwp:id="p-41">Despite these limitations, our work adds to a growing body of evidence suggesting that schizophrenia and immune diseases share genetic risk factors. There are conflicting reports in the literature with respect to the specific immune diseases demonstrating genetic overlap with schizophrenia, and the direction of effect (positive or negative genetic correlation). Genetic overlap with schizophrenia has been previously investigated for nine of the 19 immune diseases studied here. Genome-wide genetic correlation with schizophrenia has been previously reported for CRO [<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-4" hwp:rel-id="ref-23">23</xref>–<xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-3" hwp:rel-id="ref-25">25</xref>, <xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-3" hwp:rel-id="ref-27">27</xref>], MS [<xref rid="c28" ref-type="bibr" hwp:id="xref-ref-28-2" hwp:rel-id="ref-28">28</xref>], PBC [<xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-4" hwp:rel-id="ref-25">25</xref>], PSO [<xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-5" hwp:rel-id="ref-25">25</xref>, <xref rid="c29" ref-type="bibr" hwp:id="xref-ref-29-2" hwp:rel-id="ref-29">29</xref>], rheumatoid arthritis (RA, both positive [<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-5" hwp:rel-id="ref-23">23</xref>, <xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-5" hwp:rel-id="ref-24">24</xref>] and negative [<xref rid="c31" ref-type="bibr" hwp:id="xref-ref-31-2" hwp:rel-id="ref-31">31</xref>] genetic correlations), SLE [<xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-6" hwp:rel-id="ref-24">24</xref>, <xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-6" hwp:rel-id="ref-25">25</xref>], T1D [<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-6" hwp:rel-id="ref-23">23</xref>], and UC [<xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-7" hwp:rel-id="ref-24">24</xref>–<xref rid="c27" ref-type="bibr" hwp:id="xref-ref-27-4" hwp:rel-id="ref-27">27</xref>] (see <bold>S1 Table</bold> for a summary of previous studies). Our results are consistent with previously reported genetic overlap between schizophrenia and PBC [<xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-7" hwp:rel-id="ref-25">25</xref>], PSO [<xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-8" hwp:rel-id="ref-25">25</xref>], SLE [<xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-8" hwp:rel-id="ref-24">24</xref>, <xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-9" hwp:rel-id="ref-25">25</xref>], T1D [<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-7" hwp:rel-id="ref-23">23</xref>], and UC [<xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-9" hwp:rel-id="ref-24">24</xref>, <xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-10" hwp:rel-id="ref-25">25</xref>]. While we did not observe genetic correlation between schizophrenia and MS in the total sample, there was a significant sex-dependent effect with genetic correlation observed among males. We provide new evidence of genetic correlation with NAR (not previously investigated). Notably, we did not find any significant genetic correlation between schizophrenia and RA. Despite the robust inverse epidemiological association between schizophrenia and RA [<xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-4" hwp:rel-id="ref-8">8</xref>], the genetic association is less consistent. Using methods based on summary statistics (including PRS and LDSC), four previous studies reported no evidence of pleiotropy between schizophrenia and RA [<xref rid="c8" ref-type="bibr" hwp:id="xref-ref-8-5" hwp:rel-id="ref-8">8</xref>, <xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-12" hwp:rel-id="ref-16">16</xref>, <xref rid="c25" ref-type="bibr" hwp:id="xref-ref-25-11" hwp:rel-id="ref-25">25</xref>, <xref rid="c30" ref-type="bibr" hwp:id="xref-ref-30-4" hwp:rel-id="ref-30">30</xref>], while two studies reported positive genetic correlation [<xref rid="c23" ref-type="bibr" hwp:id="xref-ref-23-8" hwp:rel-id="ref-23">23</xref>, <xref rid="c24" ref-type="bibr" hwp:id="xref-ref-24-10" hwp:rel-id="ref-24">24</xref>]. Notably, Lee <italic toggle="yes">et al.</italic> reported an inverse genetic correlation – in keeping with the observed epidemiological effect – using restricted maximum likelihood (GREML), a method utilizing full genotype data which has greater statistical power to detect small pleiotropic effects than PRS or LDSC [<xref rid="c31" ref-type="bibr" hwp:id="xref-ref-31-3" hwp:rel-id="ref-31">31</xref>]. Given the modest and potentially sex-dependent genetic correlations observed in the present study, subtle differences in statistical power across studies using different statistical methods and GWAS datasets may explain these discrepant findings. As genetic samples continue to grow, and our understanding of the degree of genetic overlap expected among complex traits evolves, it will be worthwhile to revisit these analyses.</p><p hwp:id="p-42">Overall, our analyses provide statistical evidence supporting extensive pleiotropy between immune diseases and schizophrenia. Our results highlight <italic toggle="yes">EPHB4</italic>, a transmembrane receptor that coordinates cell migration and has dual roles in immune cell and neuronal pathfinding, as a promising candidate for future functional studies. More broadly, our findings indicate that common genetic variants influencing the risk of immune diseases – in particular NAR, PBC, PSO, SLE, and UC – are also involved in schizophrenia. Studies identifying the cell types and biological pathways that may be driving this genetic overlap are needed, and will hopefully provide further insights into the pathophysiology of schizophrenia. In the meantime, our work supports the emerging hypothesis that pathogenic mechanisms are shared across immune and central nervous system disorders.</p></sec><sec id="s4" hwp:id="sec-10"><title hwp:id="title-13">Materials and Methods</title><sec id="s4a" hwp:id="sec-11"><title hwp:id="title-14">Samples and quality control</title><p hwp:id="p-43">We used either imputed genotype data or summary statistics generated as described in the original GWASs. For sample details, see <bold><xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-2" hwp:rel-id="T1">Table 1</xref>.</bold></p></sec><sec id="s4b" hwp:id="sec-12"><title hwp:id="title-15">Schizophrenia dataset</title><p hwp:id="p-44">We used data from the PGC2 study [<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-4" hwp:rel-id="ref-1">1</xref>]. For analyses of non-HLA genome-wide significant risk variants for immune diseases we used publicly available summary statistics from the total dataset (52 cohorts; 35,476 cases and 46,839 controls) [<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-5" hwp:rel-id="ref-1">1</xref>]. For PRS analyses we used all 36 European ancestry case-control cohorts with available individual-level genotype data (25,629 cases and 30,976 controls). For analyses including HLA variants we used a further refined 31 European ancestry case-control cohorts (20,253 cases and 25,011 controls) with high-quality coverage of the MHC region, as previously described [<xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-4" hwp:rel-id="ref-11">11</xref>].</p></sec><sec id="s4c" hwp:id="sec-13"><title hwp:id="title-16">Immune disease datasets</title><p hwp:id="p-45">To estimate the extent of genetic overlap between schizophrenia and immune diseases, we obtained full GWAS or Immunochip summary statistics for 14 of the 19 immune diseases (five immune diseases were not included in PRS analyses due to lack of available summary statistics). We obtained publicly available summary statistics for ten immune diseases (see <bold>URLs</bold>): CEL [<xref rid="c68" ref-type="bibr" hwp:id="xref-ref-68-1" hwp:rel-id="ref-68">68</xref>], CRO [<xref rid="c69" ref-type="bibr" hwp:id="xref-ref-69-1" hwp:rel-id="ref-69">69</xref>], IBD [<xref rid="c69" ref-type="bibr" hwp:id="xref-ref-69-2" hwp:rel-id="ref-69">69</xref>], JIA [<xref rid="c70" ref-type="bibr" hwp:id="xref-ref-70-1" hwp:rel-id="ref-70">70</xref>], MS [<xref rid="c36" ref-type="bibr" hwp:id="xref-ref-36-2" hwp:rel-id="ref-36">36</xref>], NAR [<xref rid="c71" ref-type="bibr" hwp:id="xref-ref-71-1" hwp:rel-id="ref-71">71</xref>], RA [<xref rid="c72" ref-type="bibr" hwp:id="xref-ref-72-1" hwp:rel-id="ref-72">72</xref>], SLE [<xref rid="c73" ref-type="bibr" hwp:id="xref-ref-73-1" hwp:rel-id="ref-73">73</xref>], T1D [<xref rid="c74" ref-type="bibr" hwp:id="xref-ref-74-1" hwp:rel-id="ref-74">74</xref>], and UC [<xref rid="c69" ref-type="bibr" hwp:id="xref-ref-69-3" hwp:rel-id="ref-69">69</xref>]. For the following four immune diseases, we obtained summary statistics with permission from the authors: PBC [<xref rid="c75" ref-type="bibr" hwp:id="xref-ref-75-1" hwp:rel-id="ref-75">75</xref>], PSO [<xref rid="c76" ref-type="bibr" hwp:id="xref-ref-76-1" hwp:rel-id="ref-76">76</xref>], SSC [<xref rid="c77" ref-type="bibr" hwp:id="xref-ref-77-1" hwp:rel-id="ref-77">77</xref>], and VIT [<xref rid="c78" ref-type="bibr" hwp:id="xref-ref-78-1" hwp:rel-id="ref-78">78</xref>].</p></sec><sec id="s4d" hwp:id="sec-14"><title hwp:id="title-17">Testing the association of genome-wide significant risk alleles for 19 immune diseases in schizophrenia</title><p hwp:id="p-46">For each of the 19 immune diseases, we defined risk loci outside of the MHC region (chromosome 6: 25-34 Mb) using curated GWAS results from ImmunoBase (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.immunobase.org" ext-link-type="uri" xlink:href="http://www.immunobase.org" hwp:id="ext-link-3">http://www.immunobase.org</ext-link>; accessed 7 June 2015. For details, see <bold>Supplementary Methods</bold>). Notably, the majority of IBD risk variants were also risk variants for CRO and/or UC. Within the MHC region we considered only the most strongly associated HLA variant (including SNPs, imputed HLA amino acid sites, and classical alleles) for each disease based on univariate analysis in previously published studies (see <bold><xref rid="tbl2" ref-type="table" hwp:id="xref-table-wrap-2-4" hwp:rel-id="T2">Table 2</xref></bold>), because multivariate conditional analyses reporting adjusted effect sizes of independent HLA variants were not available for all immune diseases. In total there were 581 unique variants (563 non-HLA variants and 18 HLA variants) associated with any immune disease at genome-wide significance.</p><p hwp:id="p-47">First, we tested for shared direction of effect with schizophrenia among SNPs associated with each of the 19 immune diseases using the binomial sign test. Because some immune risk SNPs were associated with multiple diseases with inconsistent direction of effect, we could not evaluate shared direction of effect among the collective set of immune risk SNPs in schizophrenia.</p><p hwp:id="p-48">Next, we evaluated the collective association of SNPs associated with any immune disease. First we extracted the p-values for a pruned set of 261 LD-independent, non-HLA immune risk SNPs with linkage disequilibrium (LD) Score and minor allele frequency (MAF) information were available in the European LD Score database [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-13" hwp:rel-id="ref-16">16</xref>] from the schizophrenia PGC2 GWAS. We then quantified enrichment of these immune risk SNP associations in schizophrenia using the genomic inflation value λ. We obtained an empirical enrichment p-value by comparing this to λ values from 1,000 equal-sized sets of SNPs drawn from the schizophrenia GWAS summary data, and matched to the immune SNP set for MAF and LD score as these parameters are correlated with GWAS test statistics (see <bold>Supplementary Methods</bold> for details).</p><p hwp:id="p-49">Finally, we evaluated the association of each of the 581 variants with schizophrenia using previously published association results for non-HLA [<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-6" hwp:rel-id="ref-1">1</xref>] and HLA variants [<xref rid="c11" ref-type="bibr" hwp:id="xref-ref-11-5" hwp:rel-id="ref-11">11</xref>]. We considered SNPs associated with schizophrenia at p&lt;8.6×10<sup>−5</sup> (Bonferroni correction for 581 tests, 563 non-HLA and 18 HLA variants) to have pleiotropic effects.</p><p hwp:id="p-50">To evaluate the pleiotropic potential of immune risk variants significantly associated with schizophrenia, we performed conditional and joint analysis (COJO) using GCTA [<xref rid="c79" ref-type="bibr" hwp:id="xref-ref-79-1" hwp:rel-id="ref-79">79</xref>]. Specifically, we used COJO to perform association analyses in the PGC2 schizophrenia GWAS conditioning on the immune risk variants of interest (i.e. SNPs that were significantly associated with both an immune disease and schizophrenia). In the setting of true pleiotropy, no significant associations with schizophrenia should remain after conditioning on these immune risk variants (statistically, all p&gt;8.6×10<sup>−5</sup>). We used the 1000 Genomes Phase 3 European dataset as a reference panel to calculate LD between SNPs.</p><p hwp:id="p-51">To prioritize genes and regulatory elements driving the pleiotropic GWAS loci we identified (associated with both immune disease and schizophrenia, see <bold><xref rid="tbl3" ref-type="table" hwp:id="xref-table-wrap-3-4" hwp:rel-id="T3">Table 3</xref></bold>), we followed the analytic approach described by Wu <italic toggle="yes">et al.</italic> [<xref rid="c40" ref-type="bibr" hwp:id="xref-ref-40-2" hwp:rel-id="ref-40">40</xref>]. This approach integrates summary statistics from independent -omics methylation quantitative trait loci (mQTL) studies, expression quantitative trait loci (eQTL) studies, and GWAS to identify SNPs associated with gene expression, DNA methylation, and disease through shared genetic effects.</p><p hwp:id="p-52">We obtained mQTL and eQTL data used in Wu <italic toggle="yes">et al.</italic> [<xref rid="c40" ref-type="bibr" hwp:id="xref-ref-40-3" hwp:rel-id="ref-40">40</xref>] for genetic regions within a 2Mb window of each pleiotropic SNP. These data and the quality control measures applied have been described in detail elsewhere [<xref rid="c40" ref-type="bibr" hwp:id="xref-ref-40-4" hwp:rel-id="ref-40">40</xref>]. Briefly, mQTL summary-level SNP data were from a meta-analysis of the Brisbane Systems Genetics Study [<xref rid="c80" ref-type="bibr" hwp:id="xref-ref-80-1" hwp:rel-id="ref-80">80</xref>] and Lothian Birth Cohorts of 1921 and 1936 [<xref rid="c81" ref-type="bibr" hwp:id="xref-ref-81-1" hwp:rel-id="ref-81">81</xref>], which comprised 1,980 individuals with DNA methylation measured in peripheral blood. eQTL summary-level SNP data were from the Consortium for the Architecture of Gene Expression (CAGE) study [<xref rid="c82" ref-type="bibr" hwp:id="xref-ref-82-1" hwp:rel-id="ref-82">82</xref>], which comprised 2,765 individuals with gene expression levels measured in peripheral blood. GWAS summary-level SNP data for schizophrenia was from the PGC2 study [<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-7" hwp:rel-id="ref-1">1</xref>].</p><p hwp:id="p-53">We applied summary data-based Mendelian randomization (SMR) using GCTA [<xref rid="c79" ref-type="bibr" hwp:id="xref-ref-79-2" hwp:rel-id="ref-79">79</xref>] to test for shared associations between the pleiotropic SNPs with DNAm probes and gene expression probes, DNAm probes and schizophrenia, and gene expression probes and schizophrenia. We included DNAm and gene expression probes within 2Mb of the pleiotropic SNPs. We considered significant associations as those with P<sub>SMR</sub> &lt; 1.30×10<sup>−4</sup> (0.05/385 tagged genes) for mQTLs and P<sub>SMR</sub> &lt; 4.31×10<sup>−4</sup> for eQTLs (0.05/116 tagged genes). Next, we applied the heterogeneity in dependent instruments (HEIDI) test [<xref rid="c39" ref-type="bibr" hwp:id="xref-ref-39-2" hwp:rel-id="ref-39">39</xref>] using GCTA [<xref rid="c79" ref-type="bibr" hwp:id="xref-ref-79-3" hwp:rel-id="ref-79">79</xref>] to evaluate whether significant shared associations between DNAm, gene expression and schizophrenia were driven by linkage (i.e. separate causal variants in LD exerting genetic effects on DNAm, gene expression, and schizophrenia) or a shared pleiotropic causal variant. We considered genetic effects that passed the HEIDI test (P<sub>HEIDI</sub> &gt; 0.01) to be driven by a single causal variant. We looked for consistent SMR and HEIDI results across GWAS, mQTL, and eQTL studies to prioritize genes for future functional studies.</p></sec><sec id="s4e" hwp:id="sec-15"><title hwp:id="title-18">Testing the association of polygenic risk scores for 14 immune diseases in schizophrenia</title><p hwp:id="p-54">To evaluate whether common variants influencing risk of immune diseases collectively contribute to schizophrenia, we used PRS [<xref rid="c30" ref-type="bibr" hwp:id="xref-ref-30-5" hwp:rel-id="ref-30">30</xref>, <xref rid="c32" ref-type="bibr" hwp:id="xref-ref-32-3" hwp:rel-id="ref-32">32</xref>]. To benchmark the amount of genetic overlap between schizophrenia and immune disease, we included previously published results for bipolar disorder as a positive control [<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-6" hwp:rel-id="ref-12">12</xref>]. We used human height [<xref rid="c43" ref-type="bibr" hwp:id="xref-ref-43-3" hwp:rel-id="ref-43">43</xref>] as a negative control because – despite the inverse epidemiological relationship between height and schizophrenia previously reported [<xref rid="c65" ref-type="bibr" hwp:id="xref-ref-65-2" hwp:rel-id="ref-65">65</xref>, <xref rid="c66" ref-type="bibr" hwp:id="xref-ref-66-2" hwp:rel-id="ref-66">66</xref>] – a prior study using cross-trait LDSC reported no genetic correlation with schizophrenia [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-14" hwp:rel-id="ref-16">16</xref>].</p><p hwp:id="p-55">For 14 immune diseases with available genome-wide summary statistics we performed PRS at a range of p-value thresholds (p<sub>T</sub>) as in previous studies [<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-7" hwp:rel-id="ref-12">12</xref>]: 5×10<sup>−8</sup>, 1×10<sup>−4</sup>, 1×10<sup>−3</sup>, 0.01, 0.05, 0.1, 0.2, 0.3, 0.4, 0.5, and 1.0 (which included all LD-independent SNPs, <bold><xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-3" hwp:rel-id="T1">Table 1</xref></bold>). Due to extensive LD in the HLA region, we performed analyses both including the top HLA variant and excluding the HLA region. At each p<sub>T</sub>, we constructed GRSs for each individual <italic toggle="yes">i</italic> in the schizophrenia cohort for each immune disease <italic toggle="yes">h</italic> by calculating the sum of risk-allele dosages (<italic toggle="yes">g</italic>) weighted by their effect sizes (<italic toggle="yes">β</italic>) for that immune disease:
<disp-formula id="ueqn1" hwp:id="disp-formula-1">
<alternatives hwp:id="alternatives-1"><graphic xlink:href="068684v3_ueqn1.gif" position="float" orientation="portrait" hwp:id="graphic-7"/></alternatives>
</disp-formula>
where <italic toggle="yes">M</italic> iterates over all known risk alleles for disease <italic toggle="yes">h, β</italic><sub><italic toggle="yes">M,h</italic></sub> is the effect size (log odds ratio) of <italic toggle="yes">M</italic> in disease <italic toggle="yes">h</italic>, and <italic toggle="yes">g</italic><sub><italic toggle="yes">M,i</italic></sub> is the risk-allele dosage of <italic toggle="yes">M</italic> in individual <italic toggle="yes">i</italic>. We then performed logistic regression in R [<xref rid="c83" ref-type="bibr" hwp:id="xref-ref-83-1" hwp:rel-id="ref-83">83</xref>] using the stats package [<xref rid="c83" ref-type="bibr" hwp:id="xref-ref-83-2" hwp:rel-id="ref-83">83</xref>] to evaluate the association between schizophrenia case-status and GRSs for each immune disease. As in previous studies, statistical significance of the GRSs was estimated based on their logistic regression coefficient [<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-8" hwp:rel-id="ref-12">12</xref>, <xref rid="c30" ref-type="bibr" hwp:id="xref-ref-30-6" hwp:rel-id="ref-30">30</xref>]. Variance in schizophrenia case-status explained by the GRSs was estimated using the deviation in liability-scale R<sup>2</sup> between a null model (including 10 ancestry-informative principal components and study site) and the full model (including GRSs in addition to these covariates), calculated as previously described [<xref rid="c44" ref-type="bibr" hwp:id="xref-ref-44-2" hwp:rel-id="ref-44">44</xref>] assuming a population prevalence of schizophrenia of 1%. We also estimated Nagelkerke’s pseudo-R<sup>2</sup> using the fmsb package [<xref rid="c84" ref-type="bibr" hwp:id="xref-ref-84-1" hwp:rel-id="ref-84">84</xref>]. We considered immune diseases with GRS p&lt;0.002 at any p<sub>T</sub> to show significant genetic overlap with schizophrenia (Bonferroni correction for 14 immune diseases tested in both sexes, 0.05/(14*2)=0.002). As in previous studies [<xref rid="c12" ref-type="bibr" hwp:id="xref-ref-12-9" hwp:rel-id="ref-12">12</xref>, <xref rid="c30" ref-type="bibr" hwp:id="xref-ref-30-7" hwp:rel-id="ref-30">30</xref>] we did not use Bonferroni correction for the number of p-value thresholds, as these tests are highly correlated.</p><p hwp:id="p-56">We excluded eight schizophrenia cohorts using Wellcome Trust Case Control Consortium (WTCCC) controls, due to the use of these samples in the immune disease GWASs. The total schizophrenia sample analyzed by PRS included 37,655 subjects (28 cohorts; 17,000 cases and 20,655 controls). Sex-stratified and formal sex-PRS interaction analyses were performed among the subset of subjects with known sex (9,787 male cases and 9,284 male controls; 5,231 female cases and 9,094 female controls). For details of PRS, see <bold>Supplementary Methods</bold> and <bold><xref rid="tbl1" ref-type="table" hwp:id="xref-table-wrap-1-4" hwp:rel-id="T1">Table 1</xref></bold>.</p></sec><sec id="s4f" hwp:id="sec-16"><title hwp:id="title-19">Estimating the degree of genetic correlation between schizophrenia and 14 immune diseases</title><p hwp:id="p-57">To validate our PRS results and obtain genetic correlation (r<sub>g</sub>) estimates, we performed a secondary analysis using cross-trait LDSC for immune-mediated diseases with significant PRS associations with schizophrenia [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-15" hwp:rel-id="ref-16">16</xref>]. Cross-trait LDSC estimates the genetic correlation between two traits using GWAS summary statistics. Similar to the PRS analyses described above, we benchmarked the genetic correlations observed for immune diseases by analyzing bipolar disorder [<xref rid="c85" ref-type="bibr" hwp:id="xref-ref-85-1" hwp:rel-id="ref-85">85</xref>] as a positive control and human height [<xref rid="c43" ref-type="bibr" hwp:id="xref-ref-43-4" hwp:rel-id="ref-43">43</xref>] as a negative control.</p><p hwp:id="p-58">The statistical framework for cross-trait LDSC has been described in detail previously [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-16" hwp:rel-id="ref-16">16</xref>]. Briefly, LDSC leverages the relationship between LD and association test statistics to estimate heritability as the slope of the regression of z-scores against LD scores [<xref rid="c86" ref-type="bibr" hwp:id="xref-ref-86-1" hwp:rel-id="ref-86">86</xref>]. Cross-trait LDSC is a bivariate extension of this method which estimates genetic covariance as the slope of the regression of the products of z-scores against LD scores using the following equation [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-17" hwp:rel-id="ref-16">16</xref>]:
<disp-formula id="ueqn2" hwp:id="disp-formula-2">
<alternatives hwp:id="alternatives-2"><graphic xlink:href="068684v3_ueqn2.gif" position="float" orientation="portrait" hwp:id="graphic-8"/></alternatives>
</disp-formula>
where <italic toggle="yes">z</italic><sub><italic toggle="yes">ij</italic></sub> denotes the z score for study <italic toggle="yes">i</italic> and SNP<italic toggle="yes">j, &#x01d4c1;</italic><sub>j</sub> is the LD score [<xref rid="c86" ref-type="bibr" hwp:id="xref-ref-86-2" hwp:rel-id="ref-86">86</xref>], <italic toggle="yes">N</italic><sub>i</sub> is the sample size for study <italic toggle="yes">i, ϱ</italic><sub>g</sub> is the genetic covariance, <italic toggle="yes">M</italic> is the number of SNPs in the reference panel with MAF between 5% and 50%, <italic toggle="yes">N</italic><sub>S</sub> is the number of individuals included in both studies, and <italic toggle="yes">ϱ</italic> is the phenotypic correlation among the <italic toggle="yes">N</italic><sub>S</sub> overlapping samples. Genetic covariance <italic toggle="yes">ϱ</italic><sub>g</sub> is estimated by regressing <italic toggle="yes">z</italic><sub>1j</sub> <italic toggle="yes">z</italic><sub>2</sub> against <inline-formula id="eqn1" hwp:id="inline-formula-1"><alternatives hwp:id="alternatives-3"><inline-graphic xlink:href="068684v3_inline1.gif" hwp:id="inline-graphic-1"/></alternatives></inline-formula>, and multiplying the resulting slope by <italic toggle="yes">M</italic>. Statistical significance is assessed using block jackknifing over 200 equally sized blocks of SNPs [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-18" hwp:rel-id="ref-16">16</xref>]. Importantly, the MHC region is excluded from LDSC analyses due to its unusual LD structure and genetic architecture [<xref rid="c45" ref-type="bibr" hwp:id="xref-ref-45-2" hwp:rel-id="ref-45">45</xref>].</p><p hwp:id="p-59">Because LDSC is robust to sample sharing across GWAS [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-19" hwp:rel-id="ref-16">16</xref>], we used summary statistics from the 49 European-ancestry cohorts in the PGC2 study (31,335 cases and 38,765 controls) [<xref rid="c1" ref-type="bibr" hwp:id="xref-ref-1-8" hwp:rel-id="ref-1">1</xref>]. We used LD Scores from the “eur_w_ld_chr/” files available from <ext-link l:rel="related" l:ref-type="uri" l:ref="https://data.broadinstitute.org/alkesgroup/LDSCORE" ext-link-type="uri" xlink:href="https://data.broadinstitute.org/alkesgroup/LDSCORE" hwp:id="ext-link-4">https://data.broadinstitute.org/alkesgroup/LDSCORE</ext-link>, computed using 1000 Genomes Project [<xref rid="c87" ref-type="bibr" hwp:id="xref-ref-87-1" hwp:rel-id="ref-87">87</xref>] Europeans as a reference panel as previously described [<xref rid="c45" ref-type="bibr" hwp:id="xref-ref-45-3" hwp:rel-id="ref-45">45</xref>]. To ensure we were using well-imputed SNPS we filtered all GWAS as previously described [<xref rid="c16" ref-type="bibr" hwp:id="xref-ref-16-20" hwp:rel-id="ref-16">16</xref>], including limiting the analysis to HapMap 3 [<xref rid="c88" ref-type="bibr" hwp:id="xref-ref-88-1" hwp:rel-id="ref-88">88</xref>] SNPs as implemented in the LDSC script munge_sumstats.py (<ext-link l:rel="related" l:ref-type="uri" l:ref="https://github.com/bulik/ldsc" ext-link-type="uri" xlink:href="https://github.com/bulik/ldsc" hwp:id="ext-link-5">https://github.com/bulik/ldsc</ext-link>). We estimated liability scale h<sup>2</sup> for each trait using previously reported prevalence estimates (<bold>S6 Table</bold>), and removed datasets with h<sup>2</sup>&gt;1. Given that this was a secondary analysis, we considered traits with r<sub>g</sub> p&lt;0.05 to have significant genetic correlation with schizophrenia.</p></sec><sec id="s4g" hwp:id="sec-17"><title hwp:id="title-20">Benchmarking with epidemiological data</title><p hwp:id="p-60">To determine how much of the phenotypic correlation between schizophrenia and immune-mediated diseases was explained by the genetic correlations we observed, we used the approach previously described by Lee <italic toggle="yes">et al.</italic> [<xref rid="c31" ref-type="bibr" hwp:id="xref-ref-31-4" hwp:rel-id="ref-31">31</xref>]. Briefly, we benchmarked our significant genetic correlation estimates between schizophrenia and NAR, PBC, PSO, SLE and UC relative to the expected phenotypic correlations from epidemiological data. We obtained estimates of the population risk of schizophrenia (<italic toggle="yes">K</italic><sub><italic toggle="yes">SCZ</italic></sub>), the population risk of each immune disease (<italic toggle="yes">K</italic><sub><italic toggle="yes">IMMUNE</italic></sub>), and the probability of each immune disease among patients with schizophrenia (<italic toggle="yes">K</italic><sub><italic toggle="yes">IMMUNE</italic> | <italic toggle="yes">SCZ</italic></sub>) from the literature as referenced in <bold>S6 Table</bold>. We estimated the phenotypic correlation between schizophrenia and the immune disease of interest (<italic toggle="yes">R</italic><sub><italic toggle="yes">SCZ-IMMUNE</italic></sub>) using the following formula, as derived by Lee <italic toggle="yes">et al.</italic> [<xref rid="c31" ref-type="bibr" hwp:id="xref-ref-31-5" hwp:rel-id="ref-31">31</xref>] assuming that the phenotypic liabilities of schizophrenia (<italic toggle="yes">l</italic><sub><italic toggle="yes">SCZ</italic></sub>) and immune disease (<italic toggle="yes">l</italic><sub><italic toggle="yes">IMMUNE</italic></sub>) follow a bivariate normal distribution with mean=0 and standard deviation=1:
<disp-formula id="ueqn3" hwp:id="disp-formula-3">
<alternatives hwp:id="alternatives-4"><graphic xlink:href="068684v3_ueqn3.gif" position="float" orientation="portrait" hwp:id="graphic-9"/></alternatives>
</disp-formula>
where:</p><p hwp:id="p-61"><italic toggle="yes">t</italic><sub><italic toggle="yes">SCZ</italic></sub> is the liability threshold for schizophrenia:
<disp-formula id="ueqn4" hwp:id="disp-formula-4">
<alternatives hwp:id="alternatives-5"><graphic xlink:href="068684v3_ueqn4.gif" position="float" orientation="portrait" hwp:id="graphic-10"/></alternatives>
</disp-formula>
</p><p hwp:id="p-62"><italic toggle="yes">t</italic><sub><italic toggle="yes">IMMUNE</italic></sub> is the liability threshold for immune disease:
<disp-formula id="ueqn5" hwp:id="disp-formula-5">
<alternatives hwp:id="alternatives-6"><graphic xlink:href="068684v3_ueqn5.gif" position="float" orientation="portrait" hwp:id="graphic-11"/></alternatives>
</disp-formula>
</p><p hwp:id="p-63"><italic toggle="yes">t</italic><sub><italic toggle="yes">IMMUNE</italic> | <italic toggle="yes">SCZ</italic></sub> is the liability threshold for immune disease in those with schizophrenia:
<disp-formula id="ueqn6" hwp:id="disp-formula-6">
<alternatives hwp:id="alternatives-7"><graphic xlink:href="068684v3_ueqn6.gif" position="float" orientation="portrait" hwp:id="graphic-12"/></alternatives>
</disp-formula>
</p><p hwp:id="p-64"><italic toggle="yes">d</italic><sub><italic toggle="yes">SCZ</italic></sub> is the “height” of the normal distribution at the schizophrenia liability threshold:
<disp-formula id="ueqn7" hwp:id="disp-formula-7">
<alternatives hwp:id="alternatives-8"><graphic xlink:href="068684v3_ueqn7.gif" position="float" orientation="portrait" hwp:id="graphic-13"/></alternatives>
</disp-formula>
</p><p hwp:id="p-65"><italic toggle="yes">i</italic><sub><italic toggle="yes">SCZ</italic></sub> is the mean phenotypic liability of those with schizophrenia:
<disp-formula id="ueqn8" hwp:id="disp-formula-8">
<alternatives hwp:id="alternatives-9"><graphic xlink:href="068684v3_ueqn8.gif" position="float" orientation="portrait" hwp:id="graphic-14"/></alternatives>
</disp-formula>
</p></sec><sec id="s4h" hwp:id="sec-18"><title hwp:id="title-21">Statistical power</title><p hwp:id="p-66">Power to detect association of individual non-HLA and HLA immune risk variants in schizophrenia was calculated using the Genetic Power Calculator [<xref rid="c89" ref-type="bibr" hwp:id="xref-ref-89-1" hwp:rel-id="ref-89">89</xref>] assuming a risk allele frequency (RAF) of 0.05, disease prevalence of 1%, and significance threshold (α) of 8.6×10<sup>−5</sup>. Power for PRS was evaluated using AVENGEME [<xref rid="c90" ref-type="bibr" hwp:id="xref-ref-90-1" hwp:rel-id="ref-90">90</xref>, <xref rid="c91" ref-type="bibr" hwp:id="xref-ref-91-1" hwp:rel-id="ref-91">91</xref>], assuming disease and genetic parameters detailed in <bold>S6 Table</bold>.</p></sec></sec><sec id="s5" hwp:id="sec-19"><title hwp:id="title-22">URLs</title><p hwp:id="p-67">LD Score database: <ext-link l:rel="related" l:ref-type="uri" l:ref="ftp://atguftp.mgh.harvard.edu/brendan/1k_eur_r2_hm3snps_se_weights.RDS" ext-link-type="uri" xlink:href="ftp://atguftp.mgh.harvard.edu/brendan/1k_eur_r2_hm3snps_se_weights.RDS" hwp:id="ext-link-6">ftp://atguftp.mgh.harvard.edu/brendan/1k_eur_r2_hm3snps_se_weights.RDS</ext-link></p><p hwp:id="p-68">GWAS summary statistics:</p><list list-type="bullet" hwp:id="list-1"><list-item hwp:id="list-item-1"><p hwp:id="p-69">CEL</p><p hwp:id="p-70"><ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_cel_tr_ynka_4_19_1.tab.gz" ext-link-type="uri" xlink:href="https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_cel_tr_ynka_4_19_1.tab.gz" hwp:id="ext-link-7">https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_cel_tr_ynka_4_19_1.tab.gz</ext-link></p></list-item><list-item hwp:id="list-item-2"><p hwp:id="p-71">CRO, IBD, UC</p><p hwp:id="p-72"><ext-link l:rel="related" l:ref-type="uri" l:ref="ftp://ftp.sanger.ac.uk/pub/consortia/ibdgenetics/iibdgc-trans-ancestry-filtered-summary-stats.tgz" ext-link-type="uri" xlink:href="ftp://ftp.sanger.ac.uk/pub/consortia/ibdgenetics/iibdgc-trans-ancestry-filtered-summary-stats.tgz" hwp:id="ext-link-8">ftp://ftp.sanger.ac.uk/pub/consortia/ibdgenetics/iibdgc-trans-ancestry-filtered-summary-stats.tgz</ext-link></p></list-item><list-item hwp:id="list-item-3"><p hwp:id="p-73">JIA</p><p hwp:id="p-74"><ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_jia_hin_ks_UK_4_19_1.tab.gz" ext-link-type="uri" xlink:href="https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_jia_hin_ks_UK_4_19_1.tab.gz" hwp:id="ext-link-9">https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_jia_hin_ks_UK_4_19_1.tab.gz</ext-link></p></list-item><list-item hwp:id="list-item-4"><p hwp:id="p-75">MS</p><p hwp:id="p-76"><ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.immunobase.org/downloads/protected_data/GWAS_Data/hg19_gwas_ms_im_sgc_4_19_1.tab.gz" ext-link-type="uri" xlink:href="https://www.immunobase.org/downloads/protected_data/GWAS_Data/hg19_gwas_ms_im_sgc_4_19_1.tab.gz" hwp:id="ext-link-10">https://www.immunobase.org/downloads/protected_data/GWAS_Data/hg19_gwas_ms_im_sgc_4_19_1.tab.gz</ext-link></p></list-item><list-item hwp:id="list-item-5"><p hwp:id="p-77">NAR</p><p hwp:id="p-78"><ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_nar_fa_raco_4_19_1.tab.gz" ext-link-type="uri" xlink:href="https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_nar_fa_raco_4_19_1.tab.gz" hwp:id="ext-link-11">https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_nar_fa_raco_4_19_1.tab.gz</ext-link></p></list-item><list-item hwp:id="list-item-6"><p hwp:id="p-79">RA</p><p hwp:id="p-80"><ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.broadinstitute.org/ftp/pub/rheumatoid_arthritis/Stahl_etal_2010NG/" ext-link-type="uri" xlink:href="http://www.broadinstitute.org/ftp/pub/rheumatoid_arthritis/Stahl_etal_2010NG/" hwp:id="ext-link-12">http://www.broadinstitute.org/ftp/pub/rheumatoid_arthritis/Stahl_etal_2010NG/</ext-link></p></list-item><list-item hwp:id="list-item-7"><p hwp:id="p-81">SLE</p><p hwp:id="p-82"><ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.immunobase.org/downloads/protected_data/GWAS_Data/hg19_gwas_sle_be_ntham_4_20_0.tab.gz" ext-link-type="uri" xlink:href="https://www.immunobase.org/downloads/protected_data/GWAS_Data/hg19_gwas_sle_be_ntham_4_20_0.tab.gz" hwp:id="ext-link-13">https://www.immunobase.org/downloads/protected_data/GWAS_Data/hg19_gwas_sle_be_ntham_4_20_0.tab.gz</ext-link></p></list-item><list-item hwp:id="list-item-8"><p hwp:id="p-83">T1D</p><p hwp:id="p-84"><ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_t1d_o_nengut_meta_4_19_1.tab.gz" ext-link-type="uri" xlink:href="https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_t1d_o_nengut_meta_4_19_1.tab.gz" hwp:id="ext-link-14">https://www.immunobase.org/downloads/protected_data/iChip_Data/hg19_gwas_ic_t1d_o_nengut_meta_4_19_1.tab.gz</ext-link></p></list-item></list></sec><sec sec-type="supplementary-material" hwp:id="sec-20"><title hwp:id="title-23">Supporting information</title><supplementary-material position="float" orientation="portrait" hwp:id="DC1"><object-id pub-id-type="other" hwp:sub-type="slug">DC1</object-id><label>Pouget2019_SupplementaryInformation</label><media xlink:href="supplements/068684_file03.docx" position="float" orientation="portrait" hwp:id="media-1"/></supplementary-material><supplementary-material position="float" orientation="portrait" hwp:id="DC2"><object-id pub-id-type="other" hwp:sub-type="slug">DC2</object-id><label>Pouget2019_SupplementaryTables</label><media xlink:href="supplements/068684_file04.xlsx" position="float" orientation="portrait" hwp:id="media-2"/></supplementary-material></sec></body><back><ack hwp:id="ack-1"><title hwp:id="title-24">Acknowledgements</title><p hwp:id="p-85">We thank all study participants, and all research staff at the numerous study sites that made this research possible. Computations were performed on the Genetic Cluster Computer (GCC) hosted by SURFsara (<ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.surfsara.nl" ext-link-type="uri" xlink:href="http://www.surfsara.nl" hwp:id="ext-link-15">www.surfsara.nl</ext-link>). We thank ImmunoBase for curating genetic risk factors for the immune diseases investigated. We thank the Canadian-US PBC Consortium, the Italian PBC Genetics Study Group and the UK-PBC Consortium for sharing their summary data for the PBC GWAS. We thank the International Inflammatory Bowel Disease Genetics Consortium (IIBDGC) for providing publicly available genome-wide summary statistics for CRO, UC, and IBD. We also thank the International Multiple Sclerosis Genetics Consortium (IMSGC) and the investigators leading the GWASs for CEL, JIA, RA, SLE, and T1D for providing genome-wide summary statistics from their studies on ImmunoBase.</p><p hwp:id="p-86">This research was supported in part by a number of funding sources. This research uses resources provided by the Genetic Association Information Network (GAIN), obtained from the database of Genotypes and Phenotypes (dbGaP) found at <ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.ncbi.nlm.nih.gov/gap" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/gap" hwp:id="ext-link-16">http://www.ncbi.nlm.nih.gov/gap</ext-link> through dbGaP accession number phs000021.v3.p2; samples and associated phenotype data for this study were provided by the Molecular Genetics of Schizophrenia Collaboration (PI: Pablo V. Gejman, Evanston Northwestern Healthcare (ENH) and Northwestern University, Evanston, IL, USA). JG Pouget is supported by Fulbright Canada, the Weston Foundation, and Brain Canada through the Canada Brain Research Fund - a public-private partnership established by the Government of Canada. B Han is supported by the National Research Foundation of Korea (NRF) (grant 2016R1C1B2013126) and the Bio &amp; Medical Technology Development Program of the NRF (grant 2017M3A9B6061852) funded by the Korean government, Ministry of Science and ICT (MSIT). HM Ollila is supported by the Finnish Cultural Foundation and Academy of Finland (grant 309643). J Martin is supported by grants SAF2015-66761-P from the Spanish Ministry of Economy and Competitiveness and P12-BIO-1395 from from Consejería de Innovación, Ciencia y Tecnología, Junta de Andalucía (Spain). Y Jin, SA Santorico, and R Spritz are supported by the U.S. National Institutes of Health (NIH) grants R01AR045584, R01AR056292, X01HG007484, and P30AR057212 and by institutional research funding IUT20-46 from the Estonian Ministry of Education and Research. MD Mayes is supported by the U.S. NIH grants N01AR02251 and R01AR05528. S Raychaudhuri is supported by the U.S. NIH grants 1R01AR063759, 1R01AR062886, 1UH2AR067677-01, and U19AI111224-01 and Doris Duke Charitable Foundation grant 2013097. J Knight is the Joanne Murphy Professor in Behavioural Science. Funding for the GAIN schizophrenia sample was provided by the U.S. NIH grants R01 MH67257, R01 MH59588, R01 MH59571, R01 MH59565, R01 MH59587, R01 MH60870, R01 MH59566, R01 MH59586, R01 MH61675, R01 MH60879, R01 MH81800, U01 MH46276, U01 MH46289 U01 MH46318, U01 MH79469, and U01 MH79470 and the genotyping of samples was provided through GAIN. The funding sources did not influence the study design, data analysis, or writing of this manuscript.</p></ack><ref-list hwp:id="ref-list-1"><title hwp:id="title-25">References</title><ref id="c1" hwp:id="ref-1" hwp:rev-id="xref-ref-1-1 xref-ref-1-2 xref-ref-1-3 xref-ref-1-4 xref-ref-1-5 xref-ref-1-6 xref-ref-1-7 xref-ref-1-8"><label>1.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.1" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-1"><collab hwp:id="collab-2">Schizophrenia Working Group of the Psychiatric Genomics Consortium</collab>. <article-title hwp:id="article-title-2">Biological insights from 108 schizophrenia-associated genetic loci</article-title>. <source hwp:id="source-1">Nature</source>. <year>2014</year>;<volume>511</volume>(<issue>7510</issue>):<fpage>421</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c2" hwp:id="ref-2" hwp:rev-id="xref-ref-2-1"><label>2.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.2" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-2"><string-name name-style="western" hwp:sortable="Chan MK"><surname>Chan</surname> <given-names>MK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Krebs MO"><surname>Krebs</surname> <given-names>MO</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cox D"><surname>Cox</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Guest PC"><surname>Guest</surname> <given-names>PC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yolken RH"><surname>Yolken</surname> <given-names>RH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rahmoune H"><surname>Rahmoune</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-3">Development of a blood-based molecular biomarker test for identification of schizophrenia before disease onset</article-title>. <source hwp:id="source-2">Transl Psychiatry</source>. <year>2015</year>;<volume>5</volume>:<fpage>e601</fpage>.</citation></ref><ref id="c3" hwp:id="ref-3" hwp:rev-id="xref-ref-3-1 xref-ref-3-2 xref-ref-3-3"><label>3.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.3" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-3"><string-name name-style="western" hwp:sortable="Benros ME"><surname>Benros</surname> <given-names>ME</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nielsen PR"><surname>Nielsen</surname> <given-names>PR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nordentoft M"><surname>Nordentoft</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eaton WW"><surname>Eaton</surname> <given-names>WW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dalton SO"><surname>Dalton</surname> <given-names>SO</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mortensen PB"><surname>Mortensen</surname> <given-names>PB</given-names></string-name>. <article-title hwp:id="article-title-4">Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study</article-title>. <source hwp:id="source-3">Am J Psychiatry</source>. <year>2011</year>;<volume>168</volume>(<issue>12</issue>):<fpage>1303</fpage>–<lpage>10</lpage>.</citation></ref><ref id="c4" hwp:id="ref-4"><label>4.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.4" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-4"><string-name name-style="western" hwp:sortable="Chen SJ"><surname>Chen</surname> <given-names>SJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chao YL"><surname>Chao</surname> <given-names>YL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen CY"><surname>Chen</surname> <given-names>CY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chang CM"><surname>Chang</surname> <given-names>CM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wu EC"><surname>Wu</surname> <given-names>EC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wu CS"><surname>Wu</surname> <given-names>CS</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-5">Prevalence of autoimmune diseases in in-patients with schizophrenia: nationwide population-based study</article-title>. <source hwp:id="source-4">Br J Psychiatry</source>. <year>2012</year>;<volume>200</volume>(<issue>5</issue>):<fpage>374</fpage>–<lpage>80</lpage>.</citation></ref><ref id="c5" hwp:id="ref-5" hwp:rev-id="xref-ref-5-1 xref-ref-5-2 xref-ref-5-3 xref-ref-5-4"><label>5.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.5" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-5"><string-name name-style="western" hwp:sortable="Benros ME"><surname>Benros</surname> <given-names>ME</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pedersen MG"><surname>Pedersen</surname> <given-names>MG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rasmussen H"><surname>Rasmussen</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eaton WW"><surname>Eaton</surname> <given-names>WW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nordentoft M"><surname>Nordentoft</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mortensen PB"><surname>Mortensen</surname> <given-names>PB</given-names></string-name>. <article-title hwp:id="article-title-6">A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis</article-title>. <source hwp:id="source-5">Am J Psychiatry</source>. <year>2014</year>;<volume>171</volume>(<issue>2</issue>):<fpage>218</fpage>– <lpage>26</lpage>.</citation></ref><ref id="c6" hwp:id="ref-6" hwp:rev-id="xref-ref-6-1 xref-ref-6-2"><label>6.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.6" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-6"><string-name name-style="western" hwp:sortable="Eaton WW"><surname>Eaton</surname> <given-names>WW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Byrne M"><surname>Byrne</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ewald H"><surname>Ewald</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mors O"><surname>Mors</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen CY"><surname>Chen</surname> <given-names>CY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Agerbo E"><surname>Agerbo</surname> <given-names>E</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-7">Association of schizophrenia and autoimmune diseases: linkage of Danish national registers</article-title>. <source hwp:id="source-6">Am J Psychiatry</source>. <year>2006</year>;<volume>163</volume>(<issue>3</issue>):<fpage>521</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c7" hwp:id="ref-7" hwp:rev-id="xref-ref-7-1 xref-ref-7-2"><label>7.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.7" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-7"><string-name name-style="western" hwp:sortable="Eaton WW"><surname>Eaton</surname> <given-names>WW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pedersen MG"><surname>Pedersen</surname> <given-names>MG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nielsen PR"><surname>Nielsen</surname> <given-names>PR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mortensen PB"><surname>Mortensen</surname> <given-names>PB</given-names></string-name>. <article-title hwp:id="article-title-8">Autoimmune diseases, bipolar disorder, and non-affective psychosis</article-title>. <source hwp:id="source-7">Bipolar Disord</source>. <year>2010</year>;<volume>12</volume>(<issue>6</issue>):<fpage>638</fpage>–<lpage>46</lpage>.</citation></ref><ref id="c8" hwp:id="ref-8" hwp:rev-id="xref-ref-8-1 xref-ref-8-2 xref-ref-8-3 xref-ref-8-4 xref-ref-8-5"><label>8.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.8" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-8"><string-name name-style="western" hwp:sortable="Euesden J"><surname>Euesden</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Breen G"><surname>Breen</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Farmer A"><surname>Farmer</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="McGuffin P"><surname>McGuffin</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lewis CM"><surname>Lewis</surname> <given-names>CM</given-names></string-name>. <article-title hwp:id="article-title-9">The relationship between schizophrenia and rheumatoid arthritis revisited: genetic and epidemiological analyses</article-title>. <source hwp:id="source-8">Am J Med Genet B Neuropsychiatr Genet</source>. <year>2015</year>;<volume>168B</volume>(<issue>2</issue>):<fpage>81</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c9" hwp:id="ref-9" hwp:rev-id="xref-ref-9-1 xref-ref-9-2 xref-ref-9-3 xref-ref-9-4"><label>9.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.9" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-9"><string-name name-style="western" hwp:sortable="Sekar A"><surname>Sekar</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bialas AR"><surname>Bialas</surname> <given-names>AR</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Rivera H"><surname>de Rivera</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Davis A"><surname>Davis</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hammond TR"><surname>Hammond</surname> <given-names>TR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kamitaki N"><surname>Kamitaki</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-10">Schizophrenia risk from complex variation of complement component 4</article-title>. <source hwp:id="source-9">Nature</source>. <year>2016</year>;<volume>530</volume>(<issue>7589</issue>):<fpage>177</fpage>–<lpage>83</lpage>.</citation></ref><ref id="c10" hwp:id="ref-10" hwp:rev-id="xref-ref-10-1"><label>10.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.10" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-10"><string-name name-style="western" hwp:sortable="Yih Chen J"><surname>Yih Chen</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ling Wu Y"><surname>Ling Wu</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yin Mok M"><surname>Yin Mok</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jan Wu YJ"><surname>Jan Wu</surname> <given-names>YJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lintner KE"><surname>Lintner</surname> <given-names>KE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang CM"><surname>Wang</surname> <given-names>CM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-11">Effects of complement C4 gene copy number variations, size dichotomy, and C4A deficiency on genetic risk and clinical presentation of systemic lupus erythematosus in East Asian populations</article-title>. <source hwp:id="source-10">Arthritis Rheumatol</source>. <year>2016</year>;<volume>68</volume>(<issue>6</issue>):<fpage>1442</fpage>–<lpage>53</lpage>.</citation></ref><ref id="c11" hwp:id="ref-11" hwp:rev-id="xref-ref-11-1 xref-ref-11-2 xref-ref-11-3 xref-ref-11-4 xref-ref-11-5"><label>11.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.11" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-11"><string-name name-style="western" hwp:sortable="Pouget JG"><surname>Pouget</surname> <given-names>JG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goncalves VF"><surname>Goncalves</surname> <given-names>VF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Spain SL"><surname>Spain</surname> <given-names>SL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Finucane HK"><surname>Finucane</surname> <given-names>HK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Raychaudhuri S"><surname>Raychaudhuri</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kennedy JL"><surname>Kennedy</surname> <given-names>JL</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-12">Genome-wide association studies suggest limited immune gene enrichment in schizophrenia compared to 5 autoimmune diseases</article-title>. <source hwp:id="source-11">Schizophr Bull</source>. <year>2016</year>;<volume>42</volume>(<issue>5</issue>):<fpage>1176</fpage>–<lpage>84</lpage>.</citation></ref><ref id="c12" hwp:id="ref-12" hwp:rev-id="xref-ref-12-1 xref-ref-12-2 xref-ref-12-3 xref-ref-12-4 xref-ref-12-5 xref-ref-12-6 xref-ref-12-7 xref-ref-12-8 xref-ref-12-9"><label>12.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.12" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-12"><collab hwp:id="collab-3">Cross-Disorder Group of the Psychiatric Genomics Consortium</collab>. <article-title hwp:id="article-title-13">Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis</article-title>. <source hwp:id="source-12">Lancet</source>. <year>2013</year>;<volume>381</volume>:<fpage>1371</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c13" hwp:id="ref-13" hwp:rev-id="xref-ref-13-1 xref-ref-13-2"><label>13.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.13" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-13"><collab hwp:id="collab-4">Cross-Disorder Group of the Psychiatric Genomics Consortium</collab>. <article-title hwp:id="article-title-14">Genetic relationship between five psychiatric disorders estimated from genome-wide SNPs</article-title>. <source hwp:id="source-13">Nat Genet</source>. <year>2013</year>;<volume>45</volume>(<issue>9</issue>):<fpage>984</fpage>–<lpage>94</lpage>.</citation></ref><ref id="c14" hwp:id="ref-14" hwp:rev-id="xref-ref-14-1"><label>14.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.14" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-14"><string-name name-style="western" hwp:sortable="Voight BF"><surname>Voight</surname> <given-names>BF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Peloso GM"><surname>Peloso</surname> <given-names>GM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Orho-Melander M"><surname>Orho-Melander</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Frikke-Schmidt R"><surname>Frikke-Schmidt</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barbalic M"><surname>Barbalic</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jensen MK"><surname>Jensen</surname> <given-names>MK</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-15">Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study</article-title>. <source hwp:id="source-14">Lancet</source>. <year>2012</year>;<volume>380</volume>(<issue>9841</issue>):<fpage>572</fpage>–<lpage>80</lpage>.</citation></ref><ref id="c15" hwp:id="ref-15"><label>15.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.15" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-15"><string-name name-style="western" hwp:sortable="Do R"><surname>Do</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Willer CJ"><surname>Willer</surname> <given-names>CJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schmidt EM"><surname>Schmidt</surname> <given-names>EM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sengupta S"><surname>Sengupta</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gao C"><surname>Gao</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Peloso GM"><surname>Peloso</surname> <given-names>GM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-16">Common variants associated with plasma triglycerides and risk for coronary artery disease</article-title>. <source hwp:id="source-15">Nat Genet</source>. <year>2013</year>;<volume>45</volume>(<issue>11</issue>):<fpage>1345</fpage>–<lpage>52</lpage>.</citation></ref><ref id="c16" hwp:id="ref-16" hwp:rev-id="xref-ref-16-1 xref-ref-16-2 xref-ref-16-3 xref-ref-16-4 xref-ref-16-5 xref-ref-16-6 xref-ref-16-7 xref-ref-16-8 xref-ref-16-9 xref-ref-16-10 xref-ref-16-11 xref-ref-16-12 xref-ref-16-13 xref-ref-16-14 xref-ref-16-15 xref-ref-16-16 xref-ref-16-17 xref-ref-16-18 xref-ref-16-19 xref-ref-16-20"><label>16.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.16" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-16"><string-name name-style="western" hwp:sortable="Bulik-Sullivan B"><surname>Bulik-Sullivan</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Finucane HK"><surname>Finucane</surname> <given-names>HK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Anttila V"><surname>Anttila</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gusev A"><surname>Gusev</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Day FR"><surname>Day</surname> <given-names>FR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Loh PR"><surname>Loh</surname> <given-names>PR</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-17">An atlas of genetic correlations across human diseases and traits</article-title>. <source hwp:id="source-16">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>11</issue>):<fpage>1236</fpage>–<lpage>41</lpage>.</citation></ref><ref id="c17" hwp:id="ref-17"><label>17.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.17" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-17"><string-name name-style="western" hwp:sortable="Ellinghaus D"><surname>Ellinghaus</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jostins L"><surname>Jostins</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Spain SL"><surname>Spain</surname> <given-names>SL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cortes A"><surname>Cortes</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bethune J"><surname>Bethune</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Han B"><surname>Han</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-18">Analysis of five chronic inflammatory diseases identifies 27 new associations and highlights disease-specific patterns at shared loci</article-title>. <source hwp:id="source-17">Nat Genet</source>. <year>2016</year>;<volume>48</volume>(<issue>5</issue>):<fpage>510</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c18" hwp:id="ref-18" hwp:rev-id="xref-ref-18-1"><label>18.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.18" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-18"><collab hwp:id="collab-5">Brainstorm Consortium</collab>, <string-name name-style="western" hwp:sortable="Anttila V"><surname>Anttila</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bulik-Sullivan B"><surname>Bulik-Sullivan</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Finucane HK"><surname>Finucane</surname> <given-names>HK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Walters RK"><surname>Walters</surname> <given-names>RK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bras J"><surname>Bras</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-19">Analysis of shared heritability in common disorders of the brain</article-title>. <source hwp:id="source-18">Science</source>. <year>2018</year>;<volume>360</volume>(<issue>6395</issue>)</citation></ref><ref id="c19" hwp:id="ref-19" hwp:rev-id="xref-ref-19-1"><label>19.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.19" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-19"><string-name name-style="western" hwp:sortable="Chesmore K"><surname>Chesmore</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bartlett J"><surname>Bartlett</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Williams SM"><surname>Williams</surname> <given-names>SM</given-names></string-name>. <article-title hwp:id="article-title-20">The ubiquity of pleiotropy in human disease</article-title>. <source hwp:id="source-19">Hum Genet</source>. <year>2018</year>;<volume>137</volume>(<issue>1</issue>):<fpage>39</fpage>–<lpage>44</lpage>.</citation></ref><ref id="c20" hwp:id="ref-20"><label>20.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.20" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-20"><string-name name-style="western" hwp:sortable="Verbanck M"><surname>Verbanck</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen CY"><surname>Chen</surname> <given-names>CY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Neale B"><surname>Neale</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Do R."><surname>Do</surname> <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-21">Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases</article-title>. <source hwp:id="source-20">Nat Genet</source>. <year>2018</year>;<volume>50</volume>(<issue>5</issue>):<fpage>693</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c21" hwp:id="ref-21" hwp:rev-id="xref-ref-21-1 xref-ref-21-2"><label>21.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.21" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-21"><string-name name-style="western" hwp:sortable="Jordan DM"><surname>Jordan</surname> <given-names>DM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Verbanck M"><surname>Verbanck</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Do R."><surname>Do</surname> <given-names>R.</given-names></string-name> <article-title hwp:id="article-title-22">The landscape of pervasive horizontal pleiotropy in human genetic variation is driven by extreme polygenicity of human traits and diseases</article-title>. <source hwp:id="source-21">bioRxiv</source>. <year>2018</year>;doi: <ext-link l:rel="related" l:ref-type="uri" l:ref="https://doi.org/10.1101/416545" ext-link-type="uri" xlink:href="https://doi.org/10.1101/416545" hwp:id="ext-link-17">https://doi.org/10.1101/416545</ext-link></citation></ref><ref id="c22" hwp:id="ref-22" hwp:rev-id="xref-ref-22-1"><label>22.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.22" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-22"><string-name name-style="western" hwp:sortable="Gandal MJ"><surname>Gandal</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Haney JR"><surname>Haney</surname> <given-names>JR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Parikshak NN"><surname>Parikshak</surname> <given-names>NN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Leppa V"><surname>Leppa</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ramaswami G"><surname>Ramaswami</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hartl C"><surname>Hartl</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-23">Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap</article-title>. <source hwp:id="source-22">Science</source>. <year>2018</year>;<volume>359</volume>(<issue>6376</issue>):<fpage>693</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c23" hwp:id="ref-23" hwp:rev-id="xref-ref-23-1 xref-ref-23-2 xref-ref-23-3 xref-ref-23-4 xref-ref-23-5 xref-ref-23-6 xref-ref-23-7 xref-ref-23-8"><label>23.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.23" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-23"><string-name name-style="western" hwp:sortable="Stringer S"><surname>Stringer</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kahn RS"><surname>Kahn</surname> <given-names>RS</given-names></string-name>, <string-name name-style="western" hwp:sortable="de Witte LD"><surname>de Witte</surname> <given-names>LD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ophoff RA"><surname>Ophoff</surname> <given-names>RA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Derks EM"><surname>Derks</surname> <given-names>EM</given-names></string-name>. <article-title hwp:id="article-title-24">Genetic liability for schizophrenia predicts risk of immune disorders</article-title>. <source hwp:id="source-23">Schizophr Res</source>. <year>2014</year>;<volume>159</volume>:<fpage>347</fpage>–<lpage>52</lpage>.</citation></ref><ref id="c24" hwp:id="ref-24" hwp:rev-id="xref-ref-24-1 xref-ref-24-2 xref-ref-24-3 xref-ref-24-4 xref-ref-24-5 xref-ref-24-6 xref-ref-24-7 xref-ref-24-8 xref-ref-24-9 xref-ref-24-10"><label>24.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.24" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-24"><string-name name-style="western" hwp:sortable="Wang Q"><surname>Wang</surname> <given-names>Q</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yang C"><surname>Yang</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gelernter J"><surname>Gelernter</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhao H."><surname>Zhao</surname> <given-names>H.</given-names></string-name> <article-title hwp:id="article-title-25">Pervasive pleiotropy between psychiatric disorders and immune disorders revealed by integrative analysis of multiple GWAS</article-title>. <source hwp:id="source-24">Hum Genet</source>. <year>2015</year>;<volume>134</volume>(<issue>11-12</issue>):<fpage>1195</fpage>–<lpage>209</lpage>.</citation></ref><ref id="c25" hwp:id="ref-25" hwp:rev-id="xref-ref-25-1 xref-ref-25-2 xref-ref-25-3 xref-ref-25-4 xref-ref-25-5 xref-ref-25-6 xref-ref-25-7 xref-ref-25-8 xref-ref-25-9 xref-ref-25-10 xref-ref-25-11"><label>25.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.25" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-25"><string-name name-style="western" hwp:sortable="Tylee DS"><surname>Tylee</surname> <given-names>DS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sun J"><surname>Sun</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hess JL"><surname>Hess</surname> <given-names>JL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tahir MA"><surname>Tahir</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sharma E"><surname>Sharma</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Malik R"><surname>Malik</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-26">Genetic correlations among psychiatric and immune-related phenotypes based on genome-wide association data</article-title>. <source hwp:id="source-25">Am J Med Genet B Neuropsychiatr Genet</source>. <year>2018</year>;<volume>177</volume>(<issue>7</issue>):<fpage>641</fpage>–<lpage>57</lpage>.</citation></ref><ref id="c26" hwp:id="ref-26" hwp:rev-id="xref-ref-26-1"><label>26.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.26" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-26"><string-name name-style="western" hwp:sortable="Duncan LE"><surname>Duncan</surname> <given-names>LE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Shen H"><surname>Shen</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ballon JS"><surname>Ballon</surname> <given-names>JS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hardy KV"><surname>Hardy</surname> <given-names>KV</given-names></string-name>, <string-name name-style="western" hwp:sortable="Noordsy DL"><surname>Noordsy</surname> <given-names>DL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Levinson DF"><surname>Levinson</surname> <given-names>DF</given-names></string-name>. <article-title hwp:id="article-title-27">Genetic correlation profile of schizophrenia mirrors epidemiological results and suggests link between polygenic and rare variant (22q11.2) cases of schizophrenia</article-title>. <source hwp:id="source-26">Schizophr Bull</source>. <year>2018</year>;<volume>44</volume>(<issue>6</issue>):<fpage>1350</fpage>–<lpage>61</lpage>.</citation></ref><ref id="c27" hwp:id="ref-27" hwp:rev-id="xref-ref-27-1 xref-ref-27-2 xref-ref-27-3 xref-ref-27-4"><label>27.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.27" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-27"><string-name name-style="western" hwp:sortable="Pickrell JK"><surname>Pickrell</surname> <given-names>JK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Berisa T"><surname>Berisa</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liu JZ"><surname>Liu</surname> <given-names>JZ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Segurel L"><surname>Segurel</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tung JY"><surname>Tung</surname> <given-names>JY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hinds DA"><surname>Hinds</surname> <given-names>DA</given-names></string-name>. <article-title hwp:id="article-title-28">Detection and interpretation of shared genetic influences on 42 human traits</article-title>. <source hwp:id="source-27">Nat Genet</source>. <year>2016</year>;<volume>48</volume>(<issue>7</issue>):<fpage>709</fpage>–<lpage>17</lpage>.</citation></ref><ref id="c28" hwp:id="ref-28" hwp:rev-id="xref-ref-28-1 xref-ref-28-2"><label>28.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.28" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-28"><string-name name-style="western" hwp:sortable="Andreassen OA"><surname>Andreassen</surname> <given-names>OA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Harbo HF"><surname>Harbo</surname> <given-names>HF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang Y"><surname>Wang</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thompson WK"><surname>Thompson</surname> <given-names>WK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schork AJ"><surname>Schork</surname> <given-names>AJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mattingsdal M"><surname>Mattingsdal</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-29">Genetic pleiotropy between multiple sclerosis and schizophrenia but not bipolar disorder: differential involvement of immune-related gene loci</article-title>. <source hwp:id="source-28">Mol Psychiatry</source>. <year>2015</year>;<volume>20</volume>:<fpage>207</fpage>–<lpage>14</lpage>.</citation></ref><ref id="c29" hwp:id="ref-29" hwp:rev-id="xref-ref-29-1 xref-ref-29-2"><label>29.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.29" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-29"><string-name name-style="western" hwp:sortable="Yin X"><surname>Yin</surname> <given-names>X</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wineinger NE"><surname>Wineinger</surname> <given-names>NE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang K"><surname>Wang</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yue W"><surname>Yue</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Norgren N"><surname>Norgren</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang L"><surname>Wang</surname> <given-names>L</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-30">Common susceptibility variants are shared between schizophrenia and psoriasis in the Han Chinese population</article-title>. <source hwp:id="source-29">J Psychiatry Neurosci</source>. <year>2016</year>;<volume>41</volume>(<issue>6</issue>):<fpage>413</fpage>–<lpage>21</lpage>.</citation></ref><ref id="c30" hwp:id="ref-30" hwp:rev-id="xref-ref-30-1 xref-ref-30-2 xref-ref-30-3 xref-ref-30-4 xref-ref-30-5 xref-ref-30-6 xref-ref-30-7"><label>30.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.30" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-30"><string-name name-style="western" hwp:sortable="Purcell SM"><surname>Purcell</surname> <given-names>SM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wray NR"><surname>Wray</surname> <given-names>NR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stone JL"><surname>Stone</surname> <given-names>JL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Visscher PM"><surname>Visscher</surname> <given-names>PM</given-names></string-name>, <string-name name-style="western" hwp:sortable="O’Donovan MC"><surname>O’Donovan</surname> <given-names>MC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sullivan PF"><surname>Sullivan</surname> <given-names>PF</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-31">Common polygenic variation contributes to risk of schizophrenia and bipolar disorder</article-title>. <source hwp:id="source-30">Nature</source>. <year>2009</year>;<volume>460</volume>(<issue>7256</issue>):<fpage>748</fpage>–<lpage>52</lpage>.</citation></ref><ref id="c31" hwp:id="ref-31" hwp:rev-id="xref-ref-31-1 xref-ref-31-2 xref-ref-31-3 xref-ref-31-4 xref-ref-31-5"><label>31.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.31" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-31"><string-name name-style="western" hwp:sortable="Lee SH"><surname>Lee</surname> <given-names>SH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Byrne EM"><surname>Byrne</surname> <given-names>EM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hultman CM"><surname>Hultman</surname> <given-names>CM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kahler A"><surname>Kahler</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vinkhuyzen AA"><surname>Vinkhuyzen</surname> <given-names>AA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ripke S"><surname>Ripke</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-32">New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis</article-title>. <source hwp:id="source-31">Int J Epidemiol</source>. <year>2015</year>;<volume>44</volume>(<issue>5</issue>):<fpage>1706</fpage>–<lpage>21</lpage>.</citation></ref><ref id="c32" hwp:id="ref-32" hwp:rev-id="xref-ref-32-1 xref-ref-32-2 xref-ref-32-3"><label>32.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.32" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-32"><string-name name-style="western" hwp:sortable="Wray NR"><surname>Wray</surname> <given-names>NR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goddard ME"><surname>Goddard</surname> <given-names>ME</given-names></string-name>, <string-name name-style="western" hwp:sortable="Visscher PM"><surname>Visscher</surname> <given-names>PM</given-names></string-name>. <article-title hwp:id="article-title-33">Prediction of individual genetic risk to disease from genome-wide association studies</article-title>. <source hwp:id="source-32">Genome Res</source>. <year>2007</year>;<volume>17</volume>(<issue>10</issue>):<fpage>1520</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c33" hwp:id="ref-33" hwp:rev-id="xref-ref-33-1"><label>33.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.33" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-33"><string-name name-style="western" hwp:sortable="Fernando MM"><surname>Fernando</surname> <given-names>MM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stevens CR"><surname>Stevens</surname> <given-names>CR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Walsh EC"><surname>Walsh</surname> <given-names>EC</given-names></string-name>, <string-name name-style="western" hwp:sortable="De Jager PL"><surname>De Jager</surname> <given-names>PL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goyette P"><surname>Goyette</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Plenge RM"><surname>Plenge</surname> <given-names>RM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-34">Defining the role of the MHC in autoimmunity: a review and pooled analysis</article-title>. <source hwp:id="source-33">PLoS Genet</source>. <year>2008</year>;<volume>4</volume>:<fpage>e1000024</fpage>.</citation></ref><ref id="c34" hwp:id="ref-34" hwp:rev-id="xref-ref-34-1"><label>34.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.34" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-34"><string-name name-style="western" hwp:sortable="Franke A"><surname>Franke</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="McGovern DP"><surname>McGovern</surname> <given-names>DP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barrett JC"><surname>Barrett</surname> <given-names>JC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wang K"><surname>Wang</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Radford-Smith GL"><surname>Radford-Smith</surname> <given-names>GL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ahmad T"><surname>Ahmad</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-35">Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci</article-title>. <source hwp:id="source-34">Nat Genet</source>. <year>2010</year>;<volume>42</volume>(<issue>12</issue>):<fpage>1118</fpage>–<lpage>25</lpage>.</citation></ref><ref id="c35" hwp:id="ref-35" hwp:rev-id="xref-ref-35-1"><label>35.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.35" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-35"><string-name name-style="western" hwp:sortable="Jostins L"><surname>Jostins</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ripke S"><surname>Ripke</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Weersma RK"><surname>Weersma</surname> <given-names>RK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Duerr RH"><surname>Duerr</surname> <given-names>RH</given-names></string-name>, <string-name name-style="western" hwp:sortable="McGovern DP"><surname>McGovern</surname> <given-names>DP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hui KY"><surname>Hui</surname> <given-names>KY</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-36">Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease</article-title>. <source hwp:id="source-35">Nature</source>. <year>2012</year>;<volume>491</volume>(<issue>7422</issue>):<fpage>119</fpage>–<lpage>24</lpage>.</citation></ref><ref id="c36" hwp:id="ref-36" hwp:rev-id="xref-ref-36-1 xref-ref-36-2"><label>36.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.36" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-36"><string-name name-style="western" hwp:sortable="Beecham AH"><surname>Beecham</surname> <given-names>AH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Patsopoulos NA"><surname>Patsopoulos</surname> <given-names>NA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xifara DK"><surname>Xifara</surname> <given-names>DK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Davis MF"><surname>Davis</surname> <given-names>MF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kemppinen A"><surname>Kemppinen</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cotsapas C"><surname>Cotsapas</surname> <given-names>C</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-37">Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis</article-title>. <source hwp:id="source-36">Nat Genet</source>. <year>2013</year>;<volume>45</volume>(<issue>11</issue>):<fpage>1353</fpage>–<lpage>60</lpage>.</citation></ref><ref id="c37" hwp:id="ref-37" hwp:rev-id="xref-ref-37-1"><label>37.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.37" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-37"><string-name name-style="western" hwp:sortable="Dubois PC"><surname>Dubois</surname> <given-names>PC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Trynka G"><surname>Trynka</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Franke L"><surname>Franke</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hunt KA"><surname>Hunt</surname> <given-names>KA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Romanos J"><surname>Romanos</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Curtotti A"><surname>Curtotti</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-38">Multiple common variants for celiac disease influencing immune gene expression</article-title>. <source hwp:id="source-37">Nat Genet</source>. <year>2010</year>;<volume>42</volume>(<issue>4</issue>):<fpage>295</fpage>–<lpage>302</lpage>.</citation></ref><ref id="c38" hwp:id="ref-38" hwp:rev-id="xref-ref-38-1"><label>38.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.38" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-38"><string-name name-style="western" hwp:sortable="Yang J"><surname>Yang</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ferreira T"><surname>Ferreira</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Morris AP"><surname>Morris</surname> <given-names>AP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Medland SE"><surname>Medland</surname> <given-names>SE</given-names></string-name>, <article-title hwp:id="article-title-39">Genetic IOANTGIANTC, DIAbetes GRAM-aDIAGRAMC, et al. Conditional and joint multiple-SNP analysis of GWAS summary statistics identifies additional variants influencing complex traits</article-title>. <source hwp:id="source-38">Nat Genet</source>. <year>2012</year>;<volume>44</volume>(<issue>4</issue>):<fpage>369</fpage>–<lpage>75</lpage>, S1.</citation></ref><ref id="c39" hwp:id="ref-39" hwp:rev-id="xref-ref-39-1 xref-ref-39-2"><label>39.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.39" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-39"><string-name name-style="western" hwp:sortable="Zhu Z"><surname>Zhu</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang F"><surname>Zhang</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hu H"><surname>Hu</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bakshi A"><surname>Bakshi</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Robinson MR"><surname>Robinson</surname> <given-names>MR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Powell JE"><surname>Powell</surname> <given-names>JE</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-40">Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets</article-title>. <source hwp:id="source-39">Nat Genet</source>. <year>2016</year>;<volume>48</volume>(<issue>5</issue>):<fpage>481</fpage>–<lpage>7</lpage>.</citation></ref><ref id="c40" hwp:id="ref-40" hwp:rev-id="xref-ref-40-1 xref-ref-40-2 xref-ref-40-3 xref-ref-40-4"><label>40.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.40" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-40"><string-name name-style="western" hwp:sortable="Wu Y"><surname>Wu</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zeng J"><surname>Zeng</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang F"><surname>Zhang</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhu Z"><surname>Zhu</surname> <given-names>Z</given-names></string-name>, <string-name name-style="western" hwp:sortable="Qi T"><surname>Qi</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zheng Z"><surname>Zheng</surname> <given-names>Z</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-41">Integrative analysis of omics summary data reveals putative mechanisms underlying complex traits</article-title>. <source hwp:id="source-40">Nat Commun</source>. <year>2018</year>;<volume>9</volume>(<issue>1</issue>):<fpage>918</fpage>.</citation></ref><ref id="c41" hwp:id="ref-41" hwp:rev-id="xref-ref-41-1"><label>41.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.41" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-41"><collab hwp:id="collab-6">1000 Genomes Project Consortium</collab>, <string-name name-style="western" hwp:sortable="Auton A"><surname>Auton</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brooks LD"><surname>Brooks</surname> <given-names>LD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Durbin RM"><surname>Durbin</surname> <given-names>RM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Garrison EP"><surname>Garrison</surname> <given-names>EP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kang HM"><surname>Kang</surname> <given-names>HM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-42">A global reference for human genetic variation</article-title>. <source hwp:id="source-41">Nature</source>. <year>2015</year>;<volume>526</volume>(<issue>7571</issue>):<fpage>68</fpage>–<lpage>74</lpage>.</citation></ref><ref id="c42" hwp:id="ref-42" hwp:rev-id="xref-ref-42-1"><label>42.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.42" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-42"><string-name name-style="western" hwp:sortable="Stahl EA"><surname>Stahl</surname> <given-names>EA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wegmann D"><surname>Wegmann</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Trynka G"><surname>Trynka</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gutierrez-Achury J"><surname>Gutierrez-Achury</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Do R"><surname>Do</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Voight BF"><surname>Voight</surname> <given-names>BF</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-43">Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis</article-title>. <source hwp:id="source-42">Nat Genet</source>. <year>2012</year>;<volume>44</volume>(<issue>5</issue>):<fpage>483</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c43" hwp:id="ref-43" hwp:rev-id="xref-ref-43-1 xref-ref-43-2 xref-ref-43-3 xref-ref-43-4"><label>43.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.43" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-43"><string-name name-style="western" hwp:sortable="Wood AR"><surname>Wood</surname> <given-names>AR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Esko T"><surname>Esko</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yang J"><surname>Yang</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vedantam S"><surname>Vedantam</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pers TH"><surname>Pers</surname> <given-names>TH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gustafsson S"><surname>Gustafsson</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-44">Defining the role of common variation in the genomic and biological architecture of adult human height</article-title>. <source hwp:id="source-43">Nat Genet</source>. <year>2014</year>;<volume>46</volume>(<issue>11</issue>):<fpage>1173</fpage>–<lpage>86</lpage>.</citation></ref><ref id="c44" hwp:id="ref-44" hwp:rev-id="xref-ref-44-1 xref-ref-44-2"><label>44.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.44" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-44"><string-name name-style="western" hwp:sortable="Lee SH"><surname>Lee</surname> <given-names>SH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goddard ME"><surname>Goddard</surname> <given-names>ME</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wray NR"><surname>Wray</surname> <given-names>NR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Visscher PM"><surname>Visscher</surname> <given-names>PM</given-names></string-name>. <article-title hwp:id="article-title-45">A better coefficient of determination for genetic profile analysis</article-title>. <source hwp:id="source-44">Genet Epidemiol</source>. <year>2012</year>;<volume>36</volume>(<issue>3</issue>):<fpage>214</fpage>–<lpage>24</lpage>.</citation></ref><ref id="c45" hwp:id="ref-45" hwp:rev-id="xref-ref-45-1 xref-ref-45-2 xref-ref-45-3"><label>45.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.45" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-45"><string-name name-style="western" hwp:sortable="Finucane HK"><surname>Finucane</surname> <given-names>HK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bulik-Sullivan B"><surname>Bulik-Sullivan</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gusev A"><surname>Gusev</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Trynka G"><surname>Trynka</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Reshef Y"><surname>Reshef</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Loh PR"><surname>Loh</surname> <given-names>PR</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-46">Partitioning heritability by functional annotation using genome-wide association summary statistics</article-title>. <source hwp:id="source-45">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>11</issue>):<fpage>1228</fpage>–<lpage>35</lpage>.</citation></ref><ref id="c46" hwp:id="ref-46" hwp:rev-id="xref-ref-46-1"><label>46.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.46" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-46"><string-name name-style="western" hwp:sortable="Fairweather D"><surname>Fairweather</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Frisancho-Kiss S"><surname>Frisancho-Kiss</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rose NR"><surname>Rose</surname> <given-names>NR</given-names></string-name>. <article-title hwp:id="article-title-47">Sex differences in autoimmune disease from a pathological perspective</article-title>. <source hwp:id="source-46">Am J Pathol</source>. <year>2008</year>;<volume>173</volume>(<issue>3</issue>):<fpage>600</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c47" hwp:id="ref-47" hwp:rev-id="xref-ref-47-1"><label>47.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.47" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-47"><string-name name-style="western" hwp:sortable="Jones PA"><surname>Jones</surname> <given-names>PA</given-names></string-name>. <article-title hwp:id="article-title-48">Functions of DNA methylation: islands, start sites, gene bodies and beyond</article-title>. <source hwp:id="source-47">Nat Rev Genet</source>. <year>2012</year>;<volume>13</volume>(<issue>7</issue>):<fpage>484</fpage>–<lpage>92</lpage>.</citation></ref><ref id="c48" hwp:id="ref-48" hwp:rev-id="xref-ref-48-1"><label>48.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.48" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-48"><string-name name-style="western" hwp:sortable="Bell AC"><surname>Bell</surname> <given-names>AC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Felsenfeld G."><surname>Felsenfeld</surname> <given-names>G.</given-names></string-name> <article-title hwp:id="article-title-49">Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene</article-title>. <source hwp:id="source-48">Nature</source>. <year>2000</year>;<volume>405</volume>(<issue>6785</issue>):<fpage>482</fpage>–<lpage>5</lpage>.</citation></ref><ref id="c49" hwp:id="ref-49" hwp:rev-id="xref-ref-49-1"><label>49.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.49" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-49"><string-name name-style="western" hwp:sortable="Eden S"><surname>Eden</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Constancia M"><surname>Constancia</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hashimshony T"><surname>Hashimshony</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dean W"><surname>Dean</surname> <given-names>W</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goldstein B"><surname>Goldstein</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Johnson AC"><surname>Johnson</surname> <given-names>AC</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-50">An upstream repressor element plays a role in Igf2 imprinting</article-title>. <source hwp:id="source-49">EMBO J</source>. <year>2001</year>;<volume>20</volume>(<issue>13</issue>):<fpage>3518</fpage>–<lpage>25</lpage>.</citation></ref><ref id="c50" hwp:id="ref-50" hwp:rev-id="xref-ref-50-1"><label>50.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.50" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-50"><string-name name-style="western" hwp:sortable="Davis S"><surname>Davis</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gale NW"><surname>Gale</surname> <given-names>NW</given-names></string-name>, <string-name name-style="western" hwp:sortable="Aldrich TH"><surname>Aldrich</surname> <given-names>TH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Maisonpierre PC"><surname>Maisonpierre</surname> <given-names>PC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lhotak V"><surname>Lhotak</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pawson T"><surname>Pawson</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-51">Ligands for EPH-related receptor tyrosine kinases that require membrane attachment or clustering for activity</article-title>. <source hwp:id="source-50">Science</source>. <year>1994</year>;<volume>266</volume>(<issue>5186</issue>):<fpage>816</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c51" hwp:id="ref-51" hwp:rev-id="xref-ref-51-1"><label>51.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.51" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-51"><string-name name-style="western" hwp:sortable="Hruska M"><surname>Hruska</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dalva MB"><surname>Dalva</surname> <given-names>MB</given-names></string-name>. <article-title hwp:id="article-title-52">Ephrin regulation of synapse formation, function and plasticity</article-title>. <source hwp:id="source-51">Mol Cell Neurosci</source>. <year>2012</year>;<volume>50</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>44</lpage>.</citation></ref><ref id="c52" hwp:id="ref-52" hwp:rev-id="xref-ref-52-1"><label>52.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.52" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-52"><string-name name-style="western" hwp:sortable="Dustin ML"><surname>Dustin</surname> <given-names>ML</given-names></string-name>. <article-title hwp:id="article-title-53">Signaling at neuro/immune synapses</article-title>. <source hwp:id="source-52">J Clin Invest</source>. <year>2012</year>;<volume>122</volume>(<issue>4</issue>):<fpage>1149</fpage>–<lpage>55</lpage>.</citation></ref><ref id="c53" hwp:id="ref-53" hwp:rev-id="xref-ref-53-1"><label>53.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.53" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-53"><string-name name-style="western" hwp:sortable="Basu R"><surname>Basu</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huse M."><surname>Huse</surname> <given-names>M.</given-names></string-name> <article-title hwp:id="article-title-54">Mechanical communication at the immunological synapse</article-title>. <source hwp:id="source-53">Trends Cell Biol</source>. <year>2017</year>;<volume>27</volume>(<issue>4</issue>):<fpage>241</fpage>–<lpage>54</lpage>.</citation></ref><ref id="c54" hwp:id="ref-54" hwp:rev-id="xref-ref-54-1"><label>54.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.54" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-54"><string-name name-style="western" hwp:sortable="Sharfe N"><surname>Sharfe</surname> <given-names>N</given-names></string-name>, <string-name name-style="western" hwp:sortable="Freywald A"><surname>Freywald</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Toro A"><surname>Toro</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dadi H"><surname>Dadi</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Roifman C."><surname>Roifman</surname> <given-names>C.</given-names></string-name> <article-title hwp:id="article-title-55">Ephrin stimulation modulates T cell chemotaxis</article-title>. <source hwp:id="source-54">Eur J Immunol</source>. <year>2002</year>;<volume>32</volume>(<issue>12</issue>):<fpage>3745</fpage>–<lpage>55</lpage>.</citation></ref><ref id="c55" hwp:id="ref-55" hwp:rev-id="xref-ref-55-1"><label>55.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.55" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-55"><string-name name-style="western" hwp:sortable="Lu Q"><surname>Lu</surname> <given-names>Q</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sun EE"><surname>Sun</surname> <given-names>EE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Klein RS"><surname>Klein</surname> <given-names>RS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Flanagan JG"><surname>Flanagan</surname> <given-names>JG</given-names></string-name>. <article-title hwp:id="article-title-56">Ephrin-B reverse signaling is mediated by a novel PDZ-RGS protein and selectively inhibits G protein-coupled chemoattraction</article-title>. <source hwp:id="source-55">Cell</source>. <year>2001</year>;<volume>105</volume>(<issue>1</issue>):<fpage>69</fpage>–<lpage>79</lpage>.</citation></ref><ref id="c56" hwp:id="ref-56" hwp:rev-id="xref-ref-56-1"><label>56.</label><citation publication-type="website" citation-type="web" ref:id="068684v3.56" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-56"><collab hwp:id="collab-7">U.S. Food and Drug Administration, Centre for Drug Evaluation and Research</collab>. <source hwp:id="source-56">Sprycel (dasatinib) NDA 21986/22072 approval letter</source>, <year>2006</year> <month>June</month> 28. Retrieved 2018 November 4, from <ext-link l:rel="related" l:ref-type="uri" l:ref="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021986s000_SprycelAPPR_OV.pdf" ext-link-type="uri" xlink:href="https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021986s000_SprycelAPPR_OV.pdf" hwp:id="ext-link-18">https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021986s000_SprycelAPPR_OV.pdf</ext-link>.</citation></ref><ref id="c57" hwp:id="ref-57" hwp:rev-id="xref-ref-57-1"><label>57.</label><citation publication-type="website" citation-type="web" ref:id="068684v3.57" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-57"><collab hwp:id="collab-8">ClinicalTrials.gov [Internet]</collab>. <publisher-loc>Bethesda (MD)</publisher-loc>: <publisher-name>National Library of Medicine (US)</publisher-name>. <year>2016</year> <month>March</month> 23. <source hwp:id="source-57">Identifier: <ext-link l:rel="related" l:ref-type="CLINTRIALGOV" l:ref="NCT02717156" ext-link-type="clintrialgov" xlink:href="NCT02717156" hwp:id="ext-link-19">NCT02717156</ext-link>, Combination therapy with Pembrolizumab and sEphB4-HSA in previously treated urothelial carcinoma</source>. Available from: <ext-link l:rel="related" l:ref-type="uri" l:ref="https://clinicaltrials.gov/ct2/show/NCT02717156" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02717156" hwp:id="ext-link-20">https://clinicaltrials.gov/ct2/show/NCT02717156</ext-link>.</citation></ref><ref id="c58" hwp:id="ref-58"><label>58.</label><citation publication-type="website" citation-type="web" ref:id="068684v3.58" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-58"><collab hwp:id="collab-9">ClinicalTrials.gov [Internet]</collab>. <publisher-loc>Bethesda (MD)</publisher-loc>: <publisher-name>National Library of Medicine (US)</publisher-name>. <year>2016</year> <month>June</month> 15. <source hwp:id="source-58">Identifier <ext-link l:rel="related" l:ref-type="CLINTRIALGOV" l:ref="NCT02799485" ext-link-type="clintrialgov" xlink:href="NCT02799485" hwp:id="ext-link-21">NCT02799485</ext-link>, EphB4-HSA in treating patients with Kaposi sarcoma</source>. Available from: <ext-link l:rel="related" l:ref-type="uri" l:ref="https://clinicaltrials.gov/ct2/show/NCT02799485" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT02799485" hwp:id="ext-link-22">https://clinicaltrials.gov/ct2/show/NCT02799485</ext-link>.</citation></ref><ref id="c59" hwp:id="ref-59"><label>59.</label><citation publication-type="website" citation-type="web" ref:id="068684v3.59" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-59"><collab hwp:id="collab-10">ClinicalTrials.gov [Internet]</collab>. <publisher-loc>Bethesda (MD)</publisher-loc>: <publisher-name>National Library of Medicine (US)</publisher-name>. <year>2017</year> <month>May</month> 10. <source hwp:id="source-59">Identifier <ext-link l:rel="related" l:ref-type="CLINTRIALGOV" l:ref="NCT03146871" ext-link-type="clintrialgov" xlink:href="NCT03146871" hwp:id="ext-link-23">NCT03146871</ext-link>, Recombinant EphB4-HSA fusion protein and Azacitidine or Decitabine in treating patients with relapsed or refractory myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia previously treated with a hypomethylating agent</source>. Available from: <ext-link l:rel="related" l:ref-type="uri" l:ref="https://clinicaltrials.gov/ct2/show/NCT03146871" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT03146871" hwp:id="ext-link-24">https://clinicaltrials.gov/ct2/show/NCT03146871</ext-link>.</citation></ref><ref id="c60" hwp:id="ref-60" hwp:rev-id="xref-ref-60-1"><label>60.</label><citation publication-type="website" citation-type="web" ref:id="068684v3.60" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-60"><collab hwp:id="collab-11">ClinicalTrials.gov [Internet] C</collab>. <publisher-loc>Bethesda (MD)</publisher-loc>: <publisher-name>National Library of Medicine (US)</publisher-name>. <year>2017</year> <month>February</month> 10. <source hwp:id="source-60">Identifier: <ext-link l:rel="related" l:ref-type="CLINTRIALGOV" l:ref="NCT03049618" ext-link-type="clintrialgov" xlink:href="NCT03049618" hwp:id="ext-link-25">NCT03049618</ext-link>, Recombinant EphB4-HSA fusion protein and Pembrolizumab in treating patients with locally advanced or metastatic non-small cell lung cancer or locally recurrent or metastatic head and neck squamous cell cancer</source>. Available from: <ext-link l:rel="related" l:ref-type="uri" l:ref="https://clinicaltrials.gov/ct2/show/NCT03049618" ext-link-type="uri" xlink:href="https://clinicaltrials.gov/ct2/show/NCT03049618" hwp:id="ext-link-26">https://clinicaltrials.gov/ct2/show/NCT03049618</ext-link>.</citation></ref><ref id="c61" hwp:id="ref-61" hwp:rev-id="xref-ref-61-1"><label>61.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.61" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-61"><string-name name-style="western" hwp:sortable="Canellas F"><surname>Canellas</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lin L"><surname>Lin</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Julia MR"><surname>Julia</surname> <given-names>MR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Clemente A"><surname>Clemente</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Vives-Bauza C"><surname>Vives-Bauza</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ollila HM"><surname>Ollila</surname> <given-names>HM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-57">Dual cases of type 1 narcolepsy with schizophrenia and other psychotic disorders</article-title>. <source hwp:id="source-61">J Clin Sleep Med</source>. <year>2014</year>;<volume>10</volume>(<issue>9</issue>):<fpage>1011</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c62" hwp:id="ref-62" hwp:rev-id="xref-ref-62-1"><label>62.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.62" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-62"><string-name name-style="western" hwp:sortable="Arad M"><surname>Arad</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Weiner I."><surname>Weiner</surname> <given-names>I.</given-names></string-name> <article-title hwp:id="article-title-58">Disruption of latent inhibition induced by ovariectomy can be reversed by estradiol and clozapine as well as by co-administration of haloperidol with estradiol but not by haloperidol alone</article-title>. <source hwp:id="source-62">Psychopharmacology (Berl)</source>. <year>2009</year>;<volume>206</volume>(<issue>4</issue>):<fpage>731</fpage>–<lpage>40</lpage>.</citation></ref><ref id="c63" hwp:id="ref-63" hwp:rev-id="xref-ref-63-1"><label>63.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.63" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-63"><string-name name-style="western" hwp:sortable="Zhu ML"><surname>Zhu</surname> <given-names>ML</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bakhru P"><surname>Bakhru</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Conley B"><surname>Conley</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Nelson JS"><surname>Nelson</surname> <given-names>JS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Free M"><surname>Free</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Martin A"><surname>Martin</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-59">Sex bias in CNS autoimmune disease mediated by androgen control of autoimmune regulator</article-title>. <source hwp:id="source-63">Nat Commun</source>. <year>2016</year>;<volume>7</volume>:<fpage>11350</fpage>.</citation></ref><ref id="c64" hwp:id="ref-64" hwp:rev-id="xref-ref-64-1"><label>64.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.64" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-64"><string-name name-style="western" hwp:sortable="Markle JG"><surname>Markle</surname> <given-names>JG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Frank DN"><surname>Frank</surname> <given-names>DN</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mortin-Toth S"><surname>Mortin-Toth</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Robertson CE"><surname>Robertson</surname> <given-names>CE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Feazel LM"><surname>Feazel</surname> <given-names>LM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rolle-Kampczyk U"><surname>Rolle-Kampczyk</surname> <given-names>U</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-60">Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity</article-title>. <source hwp:id="source-64">Science</source>. <year>2013</year>;<volume>339</volume>(<issue>6123</issue>):<fpage>1084</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c65" hwp:id="ref-65" hwp:rev-id="xref-ref-65-1 xref-ref-65-2"><label>65.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.65" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-65"><string-name name-style="western" hwp:sortable="Zammit S"><surname>Zammit</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rasmussen F"><surname>Rasmussen</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Farahmand B"><surname>Farahmand</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gunnell D"><surname>Gunnell</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lewis G"><surname>Lewis</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tynelius P"><surname>Tynelius</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-61">Height and body mass index in young adulthood and risk of schizophrenia: a longitudinal study of 1 347 520 Swedish men</article-title>. <source hwp:id="source-65">Acta Psychiatr Scand</source>. <year>2007</year>;<volume>116</volume>(<issue>5</issue>):<fpage>378</fpage>–<lpage>85</lpage>.</citation></ref><ref id="c66" hwp:id="ref-66" hwp:rev-id="xref-ref-66-1 xref-ref-66-2"><label>66.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.66" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-66"><string-name name-style="western" hwp:sortable="Takayanagi Y"><surname>Takayanagi</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Petersen L"><surname>Petersen</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Laursen TM"><surname>Laursen</surname> <given-names>TM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cascella NG"><surname>Cascella</surname> <given-names>NG</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sawa A"><surname>Sawa</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mortensen PB"><surname>Mortensen</surname> <given-names>PB</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-62">Risk of schizophrenia spectrum and affective disorders associated with small for gestational age birth and height in adulthood</article-title>. <source hwp:id="source-66">Schizophr Res</source>. <year>2014</year>;<volume>160</volume>(<issue>1-3</issue>):<fpage>230</fpage>–<lpage>2</lpage>.</citation></ref><ref id="c67" hwp:id="ref-67" hwp:rev-id="xref-ref-67-1"><label>67.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.67" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-67"><string-name name-style="western" hwp:sortable="Boyle EA"><surname>Boyle</surname> <given-names>EA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li YI"><surname>Li</surname> <given-names>YI</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pritchard JK"><surname>Pritchard</surname> <given-names>JK</given-names></string-name>. <article-title hwp:id="article-title-63">An expanded view of complex traits: from polygenic to omnigenic</article-title>. <source hwp:id="source-67">Cell</source>. <year>2017</year>;<volume>169</volume>(<issue>7</issue>):<fpage>1177</fpage>–<lpage>86</lpage>.</citation></ref><ref id="c68" hwp:id="ref-68" hwp:rev-id="xref-ref-68-1"><label>68.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.68" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-68"><string-name name-style="western" hwp:sortable="Trynka G"><surname>Trynka</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hunt KA"><surname>Hunt</surname> <given-names>KA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bockett NA"><surname>Bockett</surname> <given-names>NA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Romanos J"><surname>Romanos</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mistry V"><surname>Mistry</surname> <given-names>V</given-names></string-name>, <string-name name-style="western" hwp:sortable="Szperl A"><surname>Szperl</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-64">Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease</article-title>. <source hwp:id="source-68">Nat Genet</source>. <year>2011</year>;<volume>43</volume>(<issue>12</issue>):<fpage>1193</fpage>–<lpage>201</lpage>.</citation></ref><ref id="c69" hwp:id="ref-69" hwp:rev-id="xref-ref-69-1 xref-ref-69-2 xref-ref-69-3"><label>69.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.69" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-69"><string-name name-style="western" hwp:sortable="Liu JZ"><surname>Liu</surname> <given-names>JZ</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Sommeren S"><surname>van Sommeren</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huang H"><surname>Huang</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ng SC"><surname>Ng</surname> <given-names>SC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alberts R"><surname>Alberts</surname> <given-names>R</given-names></string-name>, <string-name name-style="western" hwp:sortable="Takahashi A"><surname>Takahashi</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-65">Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations</article-title>. <source hwp:id="source-69">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>9</issue>):<fpage>979</fpage>–<lpage>86</lpage>.</citation></ref><ref id="c70" hwp:id="ref-70" hwp:rev-id="xref-ref-70-1"><label>70.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.70" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-70"><string-name name-style="western" hwp:sortable="Hinks A"><surname>Hinks</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cobb J"><surname>Cobb</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marion MC"><surname>Marion</surname> <given-names>MC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Prahalad S"><surname>Prahalad</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sudman M"><surname>Sudman</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bowes J"><surname>Bowes</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-66">Dense genotyping of immune-related disease regions identifies 14 new susceptibility loci for juvenile idiopathic arthritis</article-title>. <source hwp:id="source-70">Nat Genet</source>. <year>2013</year>;<volume>45</volume>(<issue>6</issue>):<fpage>664</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c71" hwp:id="ref-71" hwp:rev-id="xref-ref-71-1"><label>71.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.71" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-71"><string-name name-style="western" hwp:sortable="Faraco J"><surname>Faraco</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lin L"><surname>Lin</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kornum BR"><surname>Kornum</surname> <given-names>BR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Kenny EE"><surname>Kenny</surname> <given-names>EE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Trynka G"><surname>Trynka</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Einen M"><surname>Einen</surname> <given-names>M</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-67">ImmunoChip study implicates antigen presentation to T cells in narcolepsy</article-title>. <source hwp:id="source-71">PLoS Genet</source>. <year>2013</year>;<volume>9</volume>(<issue>2</issue>):<fpage>e1003270</fpage>.</citation></ref><ref id="c72" hwp:id="ref-72" hwp:rev-id="xref-ref-72-1"><label>72.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.72" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-72"><string-name name-style="western" hwp:sortable="Stahl EA"><surname>Stahl</surname> <given-names>EA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Raychaudhuri S"><surname>Raychaudhuri</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Remmers EF"><surname>Remmers</surname> <given-names>EF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Xie G"><surname>Xie</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Eyre S"><surname>Eyre</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Thomson BP"><surname>Thomson</surname> <given-names>BP</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-68">Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci</article-title>. <source hwp:id="source-72">Nat Genet</source>. <year>2010</year>;<volume>42</volume>(<issue>6</issue>):<fpage>508</fpage>–<lpage>14</lpage>.</citation></ref><ref id="c73" hwp:id="ref-73" hwp:rev-id="xref-ref-73-1"><label>73.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.73" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-73"><string-name name-style="western" hwp:sortable="Bentham J"><surname>Bentham</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Morris DL"><surname>Morris</surname> <given-names>DL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cunninghame Graham DS"><surname>Cunninghame Graham</surname> <given-names>DS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pinder CL"><surname>Pinder</surname> <given-names>CL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tombleson P"><surname>Tombleson</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Behrens TW"><surname>Behrens</surname> <given-names>TW</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-69">Genetic association analyses implicate aberrant regulation of innate and adaptive immunity genes in the pathogenesis of systemic lupus erythematosus</article-title>. <source hwp:id="source-73">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>12</issue>):<fpage>1457</fpage>–<lpage>64</lpage>.</citation></ref><ref id="c74" hwp:id="ref-74" hwp:rev-id="xref-ref-74-1"><label>74.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.74" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-74"><string-name name-style="western" hwp:sortable="Onengut-Gumuscu S"><surname>Onengut-Gumuscu</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen WM"><surname>Chen</surname> <given-names>WM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Burren O"><surname>Burren</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cooper NJ"><surname>Cooper</surname> <given-names>NJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Quinlan AR"><surname>Quinlan</surname> <given-names>AR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mychaleckyj JC"><surname>Mychaleckyj</surname> <given-names>JC</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-70">Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers</article-title>. <source hwp:id="source-74">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>4</issue>):<fpage>381</fpage>–<lpage>6</lpage>.</citation></ref><ref id="c75" hwp:id="ref-75" hwp:rev-id="xref-ref-75-1"><label>75.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.75" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-75"><string-name name-style="western" hwp:sortable="Cordell HJ"><surname>Cordell</surname> <given-names>HJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Han Y"><surname>Han</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mells GF"><surname>Mells</surname> <given-names>GF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li Y"><surname>Li</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hirschfield GM"><surname>Hirschfield</surname> <given-names>GM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Greene CS"><surname>Greene</surname> <given-names>CS</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-71">International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways</article-title>. <source hwp:id="source-75">Nat Commun</source>. <year>2015</year>;<volume>6</volume>:<fpage>8019</fpage>.</citation></ref><ref id="c76" hwp:id="ref-76" hwp:rev-id="xref-ref-76-1"><label>76.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.76" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-76"><string-name name-style="western" hwp:sortable="Strange A"><surname>Strange</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Capon F"><surname>Capon</surname> <given-names>F</given-names></string-name>, <string-name name-style="western" hwp:sortable="Spencer CC"><surname>Spencer</surname> <given-names>CC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Knight J"><surname>Knight</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Weale ME"><surname>Weale</surname> <given-names>ME</given-names></string-name>, <string-name name-style="western" hwp:sortable="Allen MH"><surname>Allen</surname> <given-names>MH</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-72">A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1</article-title>. <source hwp:id="source-76">Nat Genet</source>. <year>2010</year>;<volume>42</volume>(<issue>11</issue>):<fpage>985</fpage>–<lpage>90</lpage>.</citation></ref><ref id="c77" hwp:id="ref-77" hwp:rev-id="xref-ref-77-1"><label>77.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.77" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-77"><string-name name-style="western" hwp:sortable="Radstake TR"><surname>Radstake</surname> <given-names>TR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gorlova O"><surname>Gorlova</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rueda B"><surname>Rueda</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Martin JE"><surname>Martin</surname> <given-names>JE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Alizadeh BZ"><surname>Alizadeh</surname> <given-names>BZ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Palomino-Morales R"><surname>Palomino-Morales</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-73">Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus</article-title>. <source hwp:id="source-77">Nat Genet</source>. <year>2010</year>;<volume>42</volume>(<issue>5</issue>):<fpage>426</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c78" hwp:id="ref-78" hwp:rev-id="xref-ref-78-1"><label>78.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.78" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-78"><string-name name-style="western" hwp:sortable="Jin Y"><surname>Jin</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Andersen G"><surname>Andersen</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yorgov D"><surname>Yorgov</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ferrara TM"><surname>Ferrara</surname> <given-names>TM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ben S"><surname>Ben</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brownson KM"><surname>Brownson</surname> <given-names>KM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-74">Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants</article-title>. <source hwp:id="source-78">Nat Genet</source>. <year>2016</year>;<volume>48</volume>(<issue>11</issue>):<fpage>1418</fpage>–<lpage>24</lpage>.</citation></ref><ref id="c79" hwp:id="ref-79" hwp:rev-id="xref-ref-79-1 xref-ref-79-2 xref-ref-79-3"><label>79.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.79" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-79"><string-name name-style="western" hwp:sortable="Yang J"><surname>Yang</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee SH"><surname>Lee</surname> <given-names>SH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Goddard ME"><surname>Goddard</surname> <given-names>ME</given-names></string-name>, <string-name name-style="western" hwp:sortable="Visscher PM"><surname>Visscher</surname> <given-names>PM</given-names></string-name>. <article-title hwp:id="article-title-75">GCTA: a tool for genome-wide complex trait analysis</article-title>. <source hwp:id="source-79">Am J Hum Genet</source>. <year>2011</year>;<volume>88</volume>(<issue>1</issue>):<fpage>76</fpage>–<lpage>82</lpage>.</citation></ref><ref id="c80" hwp:id="ref-80" hwp:rev-id="xref-ref-80-1"><label>80.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.80" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-80"><string-name name-style="western" hwp:sortable="Powell JE"><surname>Powell</surname> <given-names>JE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Henders AK"><surname>Henders</surname> <given-names>AK</given-names></string-name>, <string-name name-style="western" hwp:sortable="McRae AF"><surname>McRae</surname> <given-names>AF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Caracella A"><surname>Caracella</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Smith S"><surname>Smith</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Wright MJ"><surname>Wright</surname> <given-names>MJ</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-76">The Brisbane Systems Genetics Study: genetical genomics meets complex trait genetics</article-title>. <source hwp:id="source-80">PLoS One</source>. <year>2012</year>;<volume>7</volume>(<issue>4</issue>):<fpage>e35430</fpage>.</citation></ref><ref id="c81" hwp:id="ref-81" hwp:rev-id="xref-ref-81-1"><label>81.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.81" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-81"><string-name name-style="western" hwp:sortable="Chen BH"><surname>Chen</surname> <given-names>BH</given-names></string-name>, <string-name name-style="western" hwp:sortable="Marioni RE"><surname>Marioni</surname> <given-names>RE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Colicino E"><surname>Colicino</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Peters MJ"><surname>Peters</surname> <given-names>MJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ward-Caviness CK"><surname>Ward-Caviness</surname> <given-names>CK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tsai PC"><surname>Tsai</surname> <given-names>PC</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-77">DNA methylation-based measures of biological age: meta-analysis predicting time to death</article-title>. <source hwp:id="source-81">Aging (Albany NY)</source>. <year>2016</year>;<volume>8</volume>(<issue>9</issue>):<fpage>1844</fpage>–<lpage>65</lpage>.</citation></ref><ref id="c82" hwp:id="ref-82" hwp:rev-id="xref-ref-82-1"><label>82.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.82" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-82"><string-name name-style="western" hwp:sortable="Lloyd-Jones LR"><surname>Lloyd-Jones</surname> <given-names>LR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Holloway A"><surname>Holloway</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="McRae A"><surname>McRae</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yang J"><surname>Yang</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Small K"><surname>Small</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhao J"><surname>Zhao</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-78">The genetic architecture of gene expression in peripheral blood</article-title>. <source hwp:id="source-82">Am J Hum Genet</source>. <year>2017</year>;<volume>100</volume>(<issue>2</issue>):<fpage>371</fpage>.</citation></ref><ref id="c83" hwp:id="ref-83" hwp:rev-id="xref-ref-83-1 xref-ref-83-2"><label>83.</label><citation publication-type="book" citation-type="book" ref:id="068684v3.83" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-83"><collab hwp:id="collab-12">R Core Team</collab>. <chapter-title>R: A language and environment for statistical computing</chapter-title>. <source hwp:id="source-83">R Foundation for Statistical Computing</source>. <year>2012</year>;<publisher-name>Vienna</publisher-name>, <publisher-loc>Austria</publisher-loc>. ISBN <isbn>3-900051-07-0</isbn>, URL <ext-link l:rel="related" l:ref-type="uri" l:ref="http://www.R-project.org/" ext-link-type="uri" xlink:href="http://www.R-project.org/" hwp:id="ext-link-27">http://www.R-project.org/</ext-link>.</citation></ref><ref id="c84" hwp:id="ref-84" hwp:rev-id="xref-ref-84-1"><label>84.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.84" ref:linkable="no" ref:use-reference-as-is="yes" hwp:id="citation-84"><string-name name-style="western" hwp:sortable="Nakazawa M."><surname>Nakazawa</surname> <given-names>M.</given-names></string-name> <article-title hwp:id="article-title-79">fmsb: Functions for medical statistics book with some demographic data</article-title>. <source hwp:id="source-84">R package version</source> <volume>051</volume>. <year>2014</year><ext-link l:rel="related" l:ref-type="uri" l:ref="http://CRAN.R-project.org/package=fmsb" ext-link-type="uri" xlink:href="http://CRAN.R-project.org/package=fmsb" hwp:id="ext-link-28">http://CRAN.R-project.org/package=fmsb</ext-link>.</citation></ref><ref id="c85" hwp:id="ref-85" hwp:rev-id="xref-ref-85-1"><label>85.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.85" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-85"><collab hwp:id="collab-13">Psychiatric GWAS Consortium Bipolar Disorder Working Group</collab>. <article-title hwp:id="article-title-80">Large-scale genome-wide association analysis of bipolar disorder identifies a new susceptibility locus near ODZ4</article-title>. <source hwp:id="source-85">Nat Genet</source>. <year>2011</year>;<volume>43</volume>(<issue>10</issue>):<fpage>977</fpage>–<lpage>83</lpage>.</citation></ref><ref id="c86" hwp:id="ref-86" hwp:rev-id="xref-ref-86-1 xref-ref-86-2"><label>86.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.86" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-86"><string-name name-style="western" hwp:sortable="Bulik-Sullivan BK"><surname>Bulik-Sullivan</surname> <given-names>BK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Loh PR"><surname>Loh</surname> <given-names>PR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Finucane HK"><surname>Finucane</surname> <given-names>HK</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ripke S"><surname>Ripke</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Yang J"><surname>Yang</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Patterson N"><surname>Patterson</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-81">LD Score regression distinguishes confounding from polygenicity in genome-wide association studies</article-title>. <source hwp:id="source-86">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>3</issue>):<fpage>291</fpage>–<lpage>5</lpage>.</citation></ref><ref id="c87" hwp:id="ref-87" hwp:rev-id="xref-ref-87-1"><label>87.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.87" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-87"><string-name name-style="western" hwp:sortable="Abecasis GR"><surname>Abecasis</surname> <given-names>GR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Auton A"><surname>Auton</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Brooks LD"><surname>Brooks</surname> <given-names>LD</given-names></string-name>, <string-name name-style="western" hwp:sortable="DePristo MA"><surname>DePristo</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Durbin RM"><surname>Durbin</surname> <given-names>RM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Handsaker RE"><surname>Handsaker</surname> <given-names>RE</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-82">An integrated map of genetic variation from 1,092 human genomes</article-title>. <source hwp:id="source-87">Nature</source>. <year>2012</year>;<volume>491</volume>(<issue>7422</issue>):<fpage>56</fpage>–<lpage>65</lpage>.</citation></ref><ref id="c88" hwp:id="ref-88" hwp:rev-id="xref-ref-88-1"><label>88.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.88" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-88"><collab hwp:id="collab-14">International HapMap 3 Consortium</collab>, <string-name name-style="western" hwp:sortable="Altshuler DM"><surname>Altshuler</surname> <given-names>DM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gibbs RA"><surname>Gibbs</surname> <given-names>RA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Peltonen L"><surname>Peltonen</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Altshuler DM"><surname>Altshuler</surname> <given-names>DM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gibbs RA"><surname>Gibbs</surname> <given-names>RA</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-83">Integrating common and rare genetic variation in diverse human populations</article-title>. <source hwp:id="source-88">Nature</source>. <year>2010</year>;<volume>467</volume>(<issue>7311</issue>):<fpage>52</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c89" hwp:id="ref-89" hwp:rev-id="xref-ref-89-1"><label>89.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.89" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-89"><string-name name-style="western" hwp:sortable="Purcell S"><surname>Purcell</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cherny SS"><surname>Cherny</surname> <given-names>SS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sham PC"><surname>Sham</surname> <given-names>PC</given-names></string-name>. <article-title hwp:id="article-title-84">Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits</article-title>. <source hwp:id="source-89">Bioinformatics</source>. <year>2003</year>;<volume>19</volume>(<issue>1</issue>):<fpage>149</fpage>–<lpage>50</lpage>.</citation></ref><ref id="c90" hwp:id="ref-90" hwp:rev-id="xref-ref-90-1"><label>90.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.90" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-90"><string-name name-style="western" hwp:sortable="Palla L"><surname>Palla</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dudbridge F."><surname>Dudbridge</surname> <given-names>F.</given-names></string-name> <article-title hwp:id="article-title-85">A fast method that uses polygenic scores to estimate the variance explained by genome-wide marker panels and the proportion of variants affecting a trait</article-title>. <source hwp:id="source-90">Am J Hum Genet</source>. <year>2015</year>;<volume>97</volume>(<issue>2</issue>):<fpage>250</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c91" hwp:id="ref-91" hwp:rev-id="xref-ref-91-1"><label>91.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.91" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-91"><string-name name-style="western" hwp:sortable="Dudbridge F."><surname>Dudbridge</surname> <given-names>F.</given-names></string-name> <article-title hwp:id="article-title-86">Power and predictive accuracy of polygenic risk scores</article-title>. <source hwp:id="source-91">PLoS Genet</source>. <year>2013</year>;<volume>9</volume>(<issue>3</issue>):<fpage>e1003348</fpage>.</citation></ref><ref id="c92" hwp:id="ref-92"><label>92.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.92" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-92"><string-name name-style="western" hwp:sortable="Betz RC"><surname>Betz</surname> <given-names>RC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Petukhova L"><surname>Petukhova</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ripke S"><surname>Ripke</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huang H"><surname>Huang</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Menelaou A"><surname>Menelaou</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Redler S"><surname>Redler</surname> <given-names>S</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-87">Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci</article-title>. <source hwp:id="source-92">Nat Commun</source>. <year>2015</year>;<volume>6</volume>:<fpage>5966</fpage>.</citation></ref><ref id="c93" hwp:id="ref-93"><label>93.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.93" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-93"><string-name name-style="western" hwp:sortable="Cortes A"><surname>Cortes</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hadler J"><surname>Hadler</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pointon JP"><surname>Pointon</surname> <given-names>JP</given-names></string-name>, <string-name name-style="western" hwp:sortable="Robinson PC"><surname>Robinson</surname> <given-names>PC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Karaderi T"><surname>Karaderi</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Leo P"><surname>Leo</surname> <given-names>P</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-88">Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci</article-title>. <source hwp:id="source-93">Nat Genet</source>. <year>2013</year>;<volume>45</volume>(<issue>7</issue>):<fpage>730</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c94" hwp:id="ref-94"><label>94.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.94" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-94"><string-name name-style="western" hwp:sortable="Chu X"><surname>Chu</surname> <given-names>X</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pan CM"><surname>Pan</surname> <given-names>CM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhao SX"><surname>Zhao</surname> <given-names>SX</given-names></string-name>, <string-name name-style="western" hwp:sortable="Liang J"><surname>Liang</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gao GQ"><surname>Gao</surname> <given-names>GQ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhang XM"><surname>Zhang</surname> <given-names>XM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-89">A genome-wide association study identifies two new risk loci for Graves’ disease</article-title>. <source hwp:id="source-94">Nat Genet</source>. <year>2011</year>;<volume>43</volume>(<issue>9</issue>):<fpage>897</fpage>–<lpage>901</lpage>.</citation></ref><ref id="c95" hwp:id="ref-95"><label>95.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.95" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-95"><string-name name-style="western" hwp:sortable="Gutierrez-Achury J"><surname>Gutierrez-Achury</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhernakova A"><surname>Zhernakova</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Pulit SL"><surname>Pulit</surname> <given-names>SL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Trynka G"><surname>Trynka</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hunt KA"><surname>Hunt</surname> <given-names>KA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Romanos J"><surname>Romanos</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-90">Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease</article-title>. <source hwp:id="source-95">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>6</issue>):<fpage>577</fpage>–<lpage>8</lpage>.</citation></ref><ref id="c96" hwp:id="ref-96"><label>96.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.96" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-96"><string-name name-style="western" hwp:sortable="Goyette P"><surname>Goyette</surname> <given-names>P</given-names></string-name>, <string-name name-style="western" hwp:sortable="Boucher G"><surname>Boucher</surname> <given-names>G</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mallon D"><surname>Mallon</surname> <given-names>D</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ellinghaus E"><surname>Ellinghaus</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jostins L"><surname>Jostins</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Huang H"><surname>Huang</surname> <given-names>H</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-91">High-density mapping of the MHC identifies a shared role for HLA-DRB1*01:03 in inflammatory bowel diseases and heterozygous advantage in ulcerative colitis</article-title>. <source hwp:id="source-96">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>2</issue>):<fpage>172</fpage>–<lpage>9</lpage>.</citation></ref><ref id="c97" hwp:id="ref-97"><label>97.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.97" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-97"><string-name name-style="western" hwp:sortable="Patsopoulos NA"><surname>Patsopoulos</surname> <given-names>NA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Barcellos LF"><surname>Barcellos</surname> <given-names>LF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hintzen RQ"><surname>Hintzen</surname> <given-names>RQ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Schaefer C"><surname>Schaefer</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="van Duijn CM"><surname>van Duijn</surname> <given-names>CM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Noble JA"><surname>Noble</surname> <given-names>JA</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-92">Fine-mapping the genetic association of the major histocompatibility complex in multiple sclerosis: HLA and non-HLA effects</article-title>. <source hwp:id="source-97">PLoS Genet</source>. <year>2013</year>;<volume>9</volume>(<issue>11</issue>):<fpage>e1003926</fpage>.</citation></ref><ref id="c98" hwp:id="ref-98"><label>98.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.98" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-98"><string-name name-style="western" hwp:sortable="Tafti M"><surname>Tafti</surname> <given-names>M</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hor H"><surname>Hor</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Dauvilliers Y"><surname>Dauvilliers</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lammers GJ"><surname>Lammers</surname> <given-names>GJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Overeem S"><surname>Overeem</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mayer G"><surname>Mayer</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-93">DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe</article-title>. <source hwp:id="source-98">Sleep</source>. <year>2014</year>;<volume>37</volume>(<issue>1</issue>):<fpage>19</fpage>–<lpage>25</lpage>.</citation></ref><ref id="c99" hwp:id="ref-99"><label>99.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.99" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-99"><string-name name-style="western" hwp:sortable="Liu JZ"><surname>Liu</surname> <given-names>JZ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Almarri MA"><surname>Almarri</surname> <given-names>MA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gaffney DJ"><surname>Gaffney</surname> <given-names>DJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Mells GF"><surname>Mells</surname> <given-names>GF</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jostins L"><surname>Jostins</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Cordell HJ"><surname>Cordell</surname> <given-names>HJ</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-94">Dense fine-mapping study identifies new susceptibility loci for primary biliary cirrhosis</article-title>. <source hwp:id="source-99">Nat Genet</source>. <year>2012</year>;<volume>44</volume>(<issue>10</issue>):<fpage>1137</fpage>–<lpage>41</lpage>.</citation></ref><ref id="c100" hwp:id="ref-100"><label>100.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.100" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-100"><string-name name-style="western" hwp:sortable="Liu JZ"><surname>Liu</surname> <given-names>JZ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Hov JR"><surname>Hov</surname> <given-names>JR</given-names></string-name>, <string-name name-style="western" hwp:sortable="Folseraas T"><surname>Folseraas</surname> <given-names>T</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ellinghaus E"><surname>Ellinghaus</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rushbrook SM"><surname>Rushbrook</surname> <given-names>SM</given-names></string-name>, <string-name name-style="western" hwp:sortable="Doncheva NT"><surname>Doncheva</surname> <given-names>NT</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-95">Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis</article-title>. <source hwp:id="source-100">Nat Genet</source>. <year>2013</year>;<volume>45</volume>(<issue>6</issue>):<fpage>670</fpage>–<lpage>5</lpage>.</citation></ref><ref id="c101" hwp:id="ref-101"><label>101.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.101" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-101"><string-name name-style="western" hwp:sortable="Okada Y"><surname>Okada</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Han B"><surname>Han</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tsoi LC"><surname>Tsoi</surname> <given-names>LC</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stuart PE"><surname>Stuart</surname> <given-names>PE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ellinghaus E"><surname>Ellinghaus</surname> <given-names>E</given-names></string-name>, <string-name name-style="western" hwp:sortable="Tejasvi T"><surname>Tejasvi</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-96">Fine mapping major histocompatibility complex associations in psoriasis and its clinical subtypes</article-title>. <source hwp:id="source-101">Am J Hum Genet</source>. <year>2014</year>;<volume>95</volume>(<issue>2</issue>):<fpage>162</fpage>–<lpage>72</lpage>.</citation></ref><ref id="c102" hwp:id="ref-102"><label>102.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.102" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-102"><string-name name-style="western" hwp:sortable="Raychaudhuri S"><surname>Raychaudhuri</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Sandor C"><surname>Sandor</surname> <given-names>C</given-names></string-name>, <string-name name-style="western" hwp:sortable="Stahl EA"><surname>Stahl</surname> <given-names>EA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Freudenberg J"><surname>Freudenberg</surname> <given-names>J</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee HS"><surname>Lee</surname> <given-names>HS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Jia X"><surname>Jia</surname> <given-names>X</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-97">Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis</article-title>. <source hwp:id="source-102">Nat Genet</source>. <year>2012</year>;<volume>44</volume>(<issue>3</issue>):<fpage>291</fpage>–<lpage>6</lpage>.</citation></ref><ref id="c103" hwp:id="ref-103"><label>103.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.103" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-103"><string-name name-style="western" hwp:sortable="Lessard CJ"><surname>Lessard</surname> <given-names>CJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Li H"><surname>Li</surname> <given-names>H</given-names></string-name>, <string-name name-style="western" hwp:sortable="Adrianto I"><surname>Adrianto</surname> <given-names>I</given-names></string-name>, <string-name name-style="western" hwp:sortable="Ice JA"><surname>Ice</surname> <given-names>JA</given-names></string-name>, <string-name name-style="western" hwp:sortable="Rasmussen A"><surname>Rasmussen</surname> <given-names>A</given-names></string-name>, <string-name name-style="western" hwp:sortable="Grundahl KM"><surname>Grundahl</surname> <given-names>KM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-98">Variants at multiple loci implicated in both innate and adaptive immune responses are associated with Sjogren’s syndrome</article-title>. <source hwp:id="source-103">Nat Genet</source>. <year>2013</year>;<volume>45</volume>(<issue>11</issue>):<fpage>1284</fpage>–<lpage>92</lpage>.</citation></ref><ref id="c104" hwp:id="ref-104"><label>104.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.104" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-104"><string-name name-style="western" hwp:sortable="Kim K"><surname>Kim</surname> <given-names>K</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bang SY"><surname>Bang</surname> <given-names>SY</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lee HS"><surname>Lee</surname> <given-names>HS</given-names></string-name>, <string-name name-style="western" hwp:sortable="Okada Y"><surname>Okada</surname> <given-names>Y</given-names></string-name>, <string-name name-style="western" hwp:sortable="Han B"><surname>Han</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Saw WY"><surname>Saw</surname> <given-names>WY</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-99">The HLA-DRbeta1 amino acid positions 11-13-26 explain the majority of SLE-MHC associations</article-title>. <source hwp:id="source-104">Nat Commun</source>. <year>2014</year>;<volume>5</volume>:<fpage>5902</fpage>.</citation></ref><ref id="c105" hwp:id="ref-105"><label>105.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.105" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-105"><string-name name-style="western" hwp:sortable="Mayes MD"><surname>Mayes</surname> <given-names>MD</given-names></string-name>, <string-name name-style="western" hwp:sortable="Bossini-Castillo L"><surname>Bossini-Castillo</surname> <given-names>L</given-names></string-name>, <string-name name-style="western" hwp:sortable="Gorlova O"><surname>Gorlova</surname> <given-names>O</given-names></string-name>, <string-name name-style="western" hwp:sortable="Martin JE"><surname>Martin</surname> <given-names>JE</given-names></string-name>, <string-name name-style="western" hwp:sortable="Zhou X"><surname>Zhou</surname> <given-names>X</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen WV"><surname>Chen</surname> <given-names>WV</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-100">Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis</article-title>. <source hwp:id="source-105">Am J Hum Genet</source>. <year>2014</year>;<volume>94</volume>(<issue>1</issue>):<fpage>47</fpage>–<lpage>61</lpage>.</citation></ref><ref id="c106" hwp:id="ref-106"><label>106.</label><citation publication-type="journal" citation-type="journal" ref:id="068684v3.106" ref:linkable="yes" ref:use-reference-as-is="yes" hwp:id="citation-106"><string-name name-style="western" hwp:sortable="Hu X"><surname>Hu</surname> <given-names>X</given-names></string-name>, <string-name name-style="western" hwp:sortable="Deutsch AJ"><surname>Deutsch</surname> <given-names>AJ</given-names></string-name>, <string-name name-style="western" hwp:sortable="Lenz TL"><surname>Lenz</surname> <given-names>TL</given-names></string-name>, <string-name name-style="western" hwp:sortable="Onengut-Gumuscu S"><surname>Onengut-Gumuscu</surname> <given-names>S</given-names></string-name>, <string-name name-style="western" hwp:sortable="Han B"><surname>Han</surname> <given-names>B</given-names></string-name>, <string-name name-style="western" hwp:sortable="Chen WM"><surname>Chen</surname> <given-names>WM</given-names></string-name>, <etal>et al.</etal> <article-title hwp:id="article-title-101">Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk</article-title>. <source hwp:id="source-106">Nat Genet</source>. <year>2015</year>;<volume>47</volume>(<issue>8</issue>):<fpage>898</fpage>–<lpage>905</lpage>.</citation></ref></ref-list></back></article>
